US3108097A
(en)
|
|
1963-10-22 |
|
Ehnojs |
US2809194A
(en)
|
|
1957-10-08 |
|
Thiadiazine type natriuretic agents |
US488064A
(en)
|
|
1892-12-13 |
|
Magnetic separator |
FR1103113A
(fr)
|
1954-04-15 |
1955-10-31 |
|
Triméthylol-alcanes et leur procédé de préparation
|
DE1116676B
(de)
|
1955-03-14 |
1961-11-09 |
Thomae Gmbh Dr K |
Verfahren zur Herstellung von Pyrimido [5, 4-d] pyrimidinen
|
FR1217929A
(fr)
|
1958-03-03 |
1960-05-06 |
Ciba Geigy |
Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
|
BE578515A
(zh)
|
1958-05-07 |
|
|
|
DE1302648B
(zh)
|
1960-09-27 |
|
|
|
NL281975A
(zh)
|
1961-08-12 |
|
|
|
GB1051218A
(zh)
|
1963-03-09 |
|
|
|
NL127065C
(zh)
|
1964-04-22 |
|
|
|
NL137318C
(zh)
|
1964-06-09 |
|
|
|
GB1078852A
(en)
|
1964-09-30 |
1967-08-09 |
Ici Ltd |
Alkanolamine derivatives
|
US3466325A
(en)
|
1965-04-30 |
1969-09-09 |
Haessle Ab |
1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
US3636039A
(en)
|
1970-02-24 |
1972-01-18 |
Hoffmann La Roche |
Substituted benzylimidazolidinones
|
GB1361441A
(en)
|
1970-05-13 |
1974-07-24 |
Sandoz Ltd |
Benzonaphthyridine derivatives
|
US4059622A
(en)
|
1970-05-27 |
1977-11-22 |
Imperial Chemical Industries Limited |
Alkanolamine derivatives
|
GB1338235A
(en)
|
1970-12-15 |
1973-11-21 |
May & Baker Ltd |
Azapurinones
|
DE2117571C3
(de)
|
1971-04-10 |
1979-10-11 |
Bayer Ag, 5090 Leverkusen |
Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
|
BE794964A
(fr)
|
1972-02-04 |
1973-08-02 |
Bristol Myers Co |
Nouveaux agents hypotenseurs et procede pour les preparer
|
JPS5229318B2
(zh)
|
1972-03-30 |
1977-08-01 |
|
|
DE2305339C3
(de)
|
1973-02-03 |
1980-05-08 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
|
US4062950A
(en)
|
1973-09-22 |
1977-12-13 |
Bayer Aktiengesellschaft |
Amino sugar derivatives
|
AR205004A1
(es)
|
1973-10-30 |
1976-03-31 |
Ishikawa M |
Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
|
GB1491510A
(en)
|
1973-12-14 |
1977-11-09 |
Hisamitsu Pharmaceutical Co |
1-nitrophenylquinazoline-2,4(1h,3h)-diones
|
AT334385B
(de)
|
1973-12-20 |
1976-01-10 |
Chemie Linz Ag |
Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
|
DE2462367A1
(de)
|
1974-01-22 |
1976-11-11 |
Wuelfing J A Fa |
7-(oxoalkyl)-1,3-dialkylxanthine enthaltende arzneimittelzubereitungen
|
DE2413935A1
(de)
|
1974-03-20 |
1975-10-16 |
Schering Ag |
4-(polyalkoxy-phenyl)-2-pyrrolidone
|
DE2521113A1
(de)
|
1974-05-15 |
1976-03-18 |
Maggioni & C Spa |
Cycloaliphatische derivate von 3.3-diphenylpropylamin
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
US4072746A
(en)
|
1975-10-14 |
1978-02-07 |
Sterling Drug Inc. |
3-Amino-5-(pyridinyl)-2(1H)-pyridinones
|
US4046889A
(en)
|
1976-02-13 |
1977-09-06 |
E. R. Squibb & Sons, Inc. |
Azetidine-2-carboxylic acid derivatives
|
JPS608117B2
(ja)
|
1977-02-08 |
1985-02-28 |
財団法人微生物化学研究会 |
新生理活性物質エステラスチンおよびその製造法
|
DE2719912C3
(de)
|
1977-05-04 |
1979-12-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
|
IE46852B1
(en)
|
1977-06-10 |
1983-10-05 |
Otsuka Pharma Co Ltd |
Novel carbostyril derivatives
|
DE2727481A1
(de)
|
1977-06-18 |
1979-01-11 |
Basf Ag |
Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
|
US4466972A
(en)
|
1977-06-20 |
1984-08-21 |
Sandoz Ltd. |
Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
|
NL7807507A
(nl)
|
1977-07-25 |
1979-01-29 |
Hoffmann La Roche |
Tricyclische verbindingen.
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
CA1114379A
(en)
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phthalazines
|
JPS5953920B2
(ja)
|
1977-12-28 |
1984-12-27 |
東洋醸造株式会社 |
新規なアミノ糖化合物およびその製法
|
CA1121290A
(en)
|
1978-02-14 |
1982-04-06 |
Yasuji Suhara |
Amino sugar derivatives
|
JPS54148788A
(en)
|
1978-05-15 |
1979-11-21 |
Takeda Chem Ind Ltd |
1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
|
JPS5527105A
(en)
|
1978-08-11 |
1980-02-27 |
Dai Ichi Seiyaku Co Ltd |
Imidazothienopyrimidinones compound
|
US4316906A
(en)
|
1978-08-11 |
1982-02-23 |
E. R. Squibb & Sons, Inc. |
Mercaptoacyl derivatives of substituted prolines
|
DE2837161A1
(de)
|
1978-08-25 |
1980-03-06 |
Thomae Gmbh Dr K |
Neue benzimidazole und deren verwendung
|
JPS5535019A
(en)
|
1978-09-01 |
1980-03-11 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
DE2845220A1
(de)
|
1978-10-17 |
1980-04-30 |
Yoshitomi Pharmaceutical |
Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
|
US4168267A
(en)
|
1978-10-23 |
1979-09-18 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl prolines
|
DE2847693A1
(de)
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
IL58849A
(en)
|
1978-12-11 |
1983-03-31 |
Merck & Co Inc |
Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
|
NZ193935A
(en)
|
1979-06-18 |
1985-05-31 |
Richardson Merrell Inc |
4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
GB2063249A
(en)
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
JPS5671073A
(en)
|
1979-11-12 |
1981-06-13 |
Takeda Chem Ind Ltd |
Imidazole derivative
|
JPS5671074A
(en)
|
1979-11-12 |
1981-06-13 |
Takeda Chem Ind Ltd |
1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
|
NZ195564A
(en)
|
1979-11-26 |
1983-09-30 |
Sterling Drug Inc |
5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
|
DE2951135A1
(de)
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
US4344949A
(en)
|
1980-10-03 |
1982-08-17 |
Warner-Lambert Company |
Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
ES505959A0
(es)
|
1980-10-09 |
1982-09-01 |
Hoechst Ag |
Procedimiento para la preparacion de un inactivador de alfa-amilasa
|
JPS5777676A
(en)
|
1980-10-31 |
1982-05-15 |
Otsuka Pharmaceut Co Ltd |
Carbostyril derivative
|
US4337201A
(en)
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
EP0056194B1
(en)
|
1981-01-05 |
1984-09-12 |
Takeda Chemical Industries, Ltd. |
N-substituted pseudo-aminosugars, their production and use
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
DE3107100A1
(de)
|
1981-02-20 |
1982-09-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
US4405628A
(en)
|
1981-03-05 |
1983-09-20 |
Merrell Dow Pharmaceuticals Inc. |
4-Pyridylimidazolones and method of use
|
DE3266746D1
(en)
|
1981-03-12 |
1985-11-14 |
Beecham Group Plc |
N-carboxyalkyl dipeptide derivatives and pharmaceutical compositions thereof
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
US4452813A
(en)
|
1981-05-22 |
1984-06-05 |
Taiho Pharmaceutical Company Limited |
Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
|
US4432971A
(en)
|
1981-08-03 |
1984-02-21 |
E. R. Squibb & Sons, Inc. |
Phosphonamidate compounds
|
CY1403A
(en)
|
1981-08-11 |
1987-12-18 |
Ciba Geigy Ag |
Benzazepin-2-ones
|
HU190412B
(en)
|
1981-09-17 |
1986-09-29 |
Warner-Lambert Co,Us |
Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
|
DE3226768A1
(de)
|
1981-11-05 |
1983-05-26 |
Hoechst Ag, 6230 Frankfurt |
Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
|
EP0080822A1
(en)
|
1981-11-27 |
1983-06-08 |
Beecham Group Plc |
Anti-hypertensive prolinol-based peptides
|
EP0096517A3
(en)
|
1982-06-05 |
1985-04-03 |
Smith Kline & French Laboratories Limited |
Aryl pyrazinones
|
US4452790A
(en)
|
1982-06-23 |
1984-06-05 |
E. R. Squibb & Sons, Inc. |
Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4473575A
(en)
|
1982-07-19 |
1984-09-25 |
Ciba-Geigy Corporation |
3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
IL68769A
(en)
|
1983-05-23 |
1986-02-28 |
Hadassah Med Org |
Pharmaceutical compositions containing insulin for oral administration
|
US4503030A
(en)
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
CA1247547A
(en)
|
1983-06-22 |
1988-12-28 |
Paul Hadvary |
Leucine derivatives
|
JPS6051189A
(ja)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
US4722810A
(en)
|
1984-08-16 |
1988-02-02 |
E. R. Squibb & Sons, Inc. |
Enkephalinase inhibitors
|
US4654362A
(en)
|
1983-12-05 |
1987-03-31 |
Janssen Pharmaceutica, N.V. |
Derivatives of 2,2'-iminobisethanol
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
DK520784A
(da)
|
1984-01-21 |
1985-07-22 |
Hoechst Ag |
Cycliske polypeptider, deres fremstilling og anvendelse
|
GB8406906D0
(en)
|
1984-03-16 |
1984-04-18 |
Akzo Nv |
Benzo-thiazole and benzothiophene derivatives
|
US4849405A
(en)
|
1984-05-09 |
1989-07-18 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
US4963526A
(en)
|
1984-05-09 |
1990-10-16 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
WO1985005029A1
(en)
|
1984-05-09 |
1985-11-21 |
Medaphore Inc. |
Oral insulin and a method of making the same
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
GR851085B
(zh)
|
1984-05-12 |
1985-11-25 |
Boehringer Mannheim Gmbh |
|
IL75122A
(en)
|
1984-05-14 |
1989-02-28 |
Lilly Co Eli |
3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use
|
DE3424685A1
(de)
|
1984-07-05 |
1986-02-06 |
Beiersdorf Ag, 2000 Hamburg |
Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
|
US4634765A
(en)
|
1984-12-18 |
1987-01-06 |
Merrell Dow Pharmaceuticals Inc. |
Homodisaccharide hypoglycemic agents
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
JPS61218589A
(ja)
|
1985-03-26 |
1986-09-29 |
Eisai Co Ltd |
5―(6―イミダゾ〔1,2―a〕ピリジニル)ピリジン誘導体
|
US4668506A
(en)
|
1985-08-16 |
1987-05-26 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing and amino acid polymer
|
US4931279A
(en)
|
1985-08-16 |
1990-06-05 |
Bausch & Lomb Incorporated |
Sustained release formulation containing an ion-exchange resin
|
US4713244A
(en)
|
1985-08-16 |
1987-12-15 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
|
EP0220044B1
(en)
|
1985-10-17 |
1991-01-30 |
Smith Kline & French Laboratories Limited |
4(4-oxo-1,4-dihydropyridin-1-yl)phenyl derivatives
|
IL77186A0
(en)
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
DE3543999A1
(de)
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
US5036048A
(en)
|
1986-03-07 |
1991-07-30 |
Schering Corporation |
Angiotensin II receptor blockers as antiglaucoma agents
|
WO1987006576A1
(en)
|
1986-04-29 |
1987-11-05 |
Pfizer Inc. |
Calcium independent camp phosphodiesterase inhibitor antidepressant
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US4749688A
(en)
|
1986-06-20 |
1988-06-07 |
Schering Corporation |
Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
US5138069A
(en)
|
1986-07-11 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
DE3779374D1
(en)
|
1986-08-28 |
1992-07-02 |
Sandoz Ag |
Xanthinderivate.
|
NZ222843A
(en)
|
1986-12-22 |
1989-10-27 |
Ortho Pharma Corp |
Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
|
GB8630702D0
(en)
|
1986-12-23 |
1987-02-04 |
Wellcome Found |
Quinoline compound
|
EP0583821B1
(en)
|
1987-01-23 |
2000-03-29 |
The General Hospital Corporation |
Hydralazine as topical treatment for glaucoma
|
CA1303037C
(en)
|
1987-02-02 |
1992-06-09 |
Smith Kline & French Laboratories Limited |
Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
US5041152A
(en)
|
1987-03-26 |
1991-08-20 |
Kabushiki Kaisha Toshiba |
Apparatus for bending tubular glass
|
AU614965B2
(en)
|
1987-06-06 |
1991-09-19 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Thiadiazinones
|
NZ225447A
(en)
|
1987-07-20 |
1991-12-23 |
Merck & Co Inc |
Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
|
ES2137915T3
(es)
|
1987-09-04 |
2000-01-01 |
Beecham Group Plc |
Derivados de tiazolidindiona sustituida.
|
US6288095B1
(en)
|
1987-09-04 |
2001-09-11 |
Beecham Group P.L.C. |
Compounds
|
GB2209937B
(en)
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US5192772A
(en)
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
US5015651A
(en)
|
1988-01-07 |
1991-05-14 |
E. I. Du Pont De Nemours And Company |
Treatment of hypertension with 1,2,4-angiotensin II antagonists
|
US4880804A
(en)
|
1988-01-07 |
1989-11-14 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking benzimidazoles
|
CA1338238C
(en)
|
1988-01-07 |
1996-04-09 |
David John Carini |
Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
|
DE68907066T2
(de)
|
1988-01-29 |
1993-12-16 |
Koken Kk |
Verbesserte Formulierungen mit kontrollierter Abgabe.
|
JP2717687B2
(ja)
|
1988-02-13 |
1998-02-18 |
日本曹達株式会社 |
ピリダジノン誘導体及びその製造方法
|
US5142096A
(en)
|
1988-03-31 |
1992-08-25 |
Kyowa Hakko Kogyo Co., Ltd. |
2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds
|
GB8812490D0
(en)
|
1988-05-26 |
1988-06-29 |
Agricultural & Food Res |
Delayed release formulations
|
EP0344383A1
(en)
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Novel alpha-Glucosidase inhibitors
|
JP2792862B2
(ja)
|
1988-07-30 |
1998-09-03 |
寛治 高田 |
経口腸溶製剤
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
US5106834A
(en)
|
1988-12-27 |
1992-04-21 |
G. D. Searle & Co. |
Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
|
US4916129A
(en)
|
1989-01-19 |
1990-04-10 |
E. I. Du Pont De Nemours And Company |
Combination β-blocking/angiotensin II blocking antihypertensives
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
DE3928177A1
(de)
|
1989-04-08 |
1991-02-28 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
CA2065364A1
(en)
|
1989-04-17 |
1990-10-18 |
Hermann Amschler |
Arylpyridazines, their manufacture, use and medicaments containing them
|
CA2016710A1
(en)
|
1989-05-15 |
1990-11-15 |
Prasun K. Chakravarty |
Substituted benzimidazoles as angiotensin ii antagonists
|
GB8911854D0
(en)
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
IE64514B1
(en)
|
1989-05-23 |
1995-08-09 |
Zeneca Ltd |
Azaindenes
|
IL94390A
(en)
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
US5157026A
(en)
|
1989-05-30 |
1992-10-20 |
Merck & Co., Inc. |
Oxo-purines as angiotensin II antagonists
|
US5102880A
(en)
|
1989-05-30 |
1992-04-07 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
US5064825A
(en)
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
CA2018438C
(en)
|
1989-06-14 |
2000-08-08 |
Joseph Alan Finkelstein |
Imidazolyl-alkenoic acids
|
EP0403158A3
(en)
|
1989-06-14 |
1991-12-18 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids
|
US5185351A
(en)
|
1989-06-14 |
1993-02-09 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
ATE134368T1
(de)
|
1989-06-30 |
1996-03-15 |
Du Pont |
Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
|
KR950009860B1
(ko)
|
1989-06-30 |
1995-08-29 |
이. 아이. 듀퐁 드 네모아 앤드 캄파니 |
융합된 환 아릴 치환된 이미다졸과 약제학적으로 허용되는 이의 염, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
|
CA2020073A1
(en)
|
1989-07-03 |
1991-01-04 |
Eric E. Allen |
Substituted quinazolinones as angiotensin ii antagonists
|
US5164407A
(en)
|
1989-07-03 |
1992-11-17 |
Merck & Co., Inc. |
Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
|
EP0407342A3
(en)
|
1989-07-06 |
1991-07-10 |
Ciba-Geigy Ag |
Pyrimidine derivatives
|
NZ234186A
(en)
|
1989-07-07 |
1991-10-25 |
Janssen Pharmaceutica Nv |
Imidazo quinazolin-one derivatives and pharmaceutical compositions
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
EP0409332A3
(en)
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
EP0412594B1
(en)
|
1989-07-28 |
1996-01-03 |
Merck & Co. Inc. |
Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
|
CH679207A5
(zh)
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
EP0411507B1
(en)
|
1989-08-02 |
1994-10-26 |
Takeda Chemical Industries, Ltd. |
Pyrazole derivatives, their production and use
|
NZ234854A
(en)
|
1989-08-11 |
1993-02-25 |
Ici Plc |
Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof
|
JP2862576B2
(ja)
|
1989-08-14 |
1999-03-03 |
日産自動車株式会社 |
カチオン電着塗料組成物
|
US5100897A
(en)
|
1989-08-28 |
1992-03-31 |
Merck & Co., Inc. |
Substituted pyrimidinones as angiotensin ii antagonists
|
EP0415886A3
(en)
|
1989-08-30 |
1991-10-23 |
Ciba-Geigy Ag |
Aza compounds
|
IE70593B1
(en)
|
1989-09-29 |
1996-12-11 |
Eisai Co Ltd |
Biphenylmethane derivative the use of it and pharmacological compositions containing same
|
EP0424317A3
(en)
|
1989-10-19 |
1991-09-25 |
Ciba-Geigy Ag |
Pyrimidines
|
IL95975A
(en)
|
1989-10-24 |
1997-06-10 |
Takeda Chemical Industries Ltd |
N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
|
AU640417B2
(en)
|
1989-10-25 |
1993-08-26 |
Smithkline Beecham Corporation |
Substituted 5-((tetrazolyl)alkenyl)imidazoles
|
IL96019A0
(en)
|
1989-10-31 |
1991-07-18 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
CA2028925A1
(en)
|
1989-11-06 |
1991-05-07 |
Gerald R. Girard |
Substituted n-(imidazolyl)alkyl alanine derivatives
|
HU215441B
(hu)
|
1989-11-13 |
1999-04-28 |
Pfizer Inc. |
Eljárás az endo-biciklo [2.2.1]-heptan-2-ol előállítására és az ebből kapott hatóanyagok enzimatikus úton történő elválasztására
|
US5391571A
(en)
|
1989-11-15 |
1995-02-21 |
American Home Products Corporation |
Cholesterol ester hydrolase inhibitors
|
PT95899A
(pt)
|
1989-11-17 |
1991-09-13 |
Glaxo Group Ltd |
Processo para a preparacao de derivados indole
|
IE903911A1
(en)
|
1989-11-20 |
1991-05-22 |
Ici Plc |
Diazine derivatives
|
US5073566A
(en)
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
GB8927277D0
(en)
|
1989-12-01 |
1990-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
EP0430709A3
(en)
|
1989-12-01 |
1992-02-12 |
Glaxo Group Limited |
Benzthiophen derivatives
|
EP0430300A3
(en)
|
1989-12-01 |
1992-03-25 |
Takeda Chemical Industries, Ltd. |
Xanthine derivatives, their production and use
|
US5104891A
(en)
|
1989-12-11 |
1992-04-14 |
G. D. Searle & Co. |
Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
|
EP0433983B1
(en)
|
1989-12-20 |
1998-03-04 |
Texas Instruments Incorporated |
Copper etch process using halides
|
EP0434038A1
(en)
|
1989-12-22 |
1991-06-26 |
Takeda Chemical Industries, Ltd. |
Fused imidazole derivatives, their production and use
|
GB8929208D0
(en)
|
1989-12-27 |
1990-02-28 |
Almirall Lab |
New xanthine derivatives
|
EP0435827A3
(en)
|
1989-12-28 |
1991-11-13 |
Ciba-Geigy Ag |
Diaza compounds
|
CA2032289A1
(en)
|
1989-12-29 |
1991-06-30 |
Joseph A. Finkelstein |
Substituted 5-(alkyl) carboxamide imidazoles
|
JPH05503530A
(ja)
|
1990-02-13 |
1993-06-10 |
メルク・エンド・カムパニー・インコーポレーテツド |
置換ベンジル成分を含むアンギオテンシン2拮抗物質
|
JP2726563B2
(ja)
|
1990-02-13 |
1998-03-11 |
メルク・エンド・カムパニー・インコーポレーテツド |
置換ベンジル要素を含むトリアゾールアンギオテンシン▲ii▼拮抗物質
|
CA2036304C
(en)
|
1990-02-15 |
2001-04-17 |
Takehiko Naka |
Pyrimidinedione derivatives, their production and use
|
DE122007000050I1
(de)
|
1990-02-19 |
2007-11-08 |
Novartis Ag |
Acylverbindungen
|
CA2036618C
(en)
|
1990-02-22 |
2002-10-29 |
Akira Morimoto |
Fused thiophene derivatives, their production and use
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
DE4006693A1
(de)
|
1990-03-01 |
1991-09-05 |
Schering Ag |
Neue benzimidazolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
GB9005354D0
(en)
|
1990-03-09 |
1990-05-02 |
Glaxo Group Ltd |
Chemical compounds
|
US5287273A
(en)
|
1990-03-15 |
1994-02-15 |
Mount Sinai School Of Medicine |
Functional organ images
|
FR2659655B1
(fr)
|
1990-03-19 |
1992-07-24 |
Union Pharma Scient Appl |
Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
US5140037A
(en)
|
1990-03-20 |
1992-08-18 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
|
FR2681067B1
(fr)
|
1991-09-10 |
1993-12-17 |
Elf Sanofi |
Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5173494A
(en)
|
1990-03-20 |
1992-12-22 |
E. I. Du Pont De Nemours And Company |
Specific inhibition of angiotensin-II binding to angiotensin-II receptor subtype-2
|
PT97078B
(pt)
|
1990-03-20 |
1997-07-31 |
Sanofi Sa |
Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
|
US5137906A
(en)
|
1990-03-20 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonists
|
US5155126A
(en)
|
1990-03-20 |
1992-10-13 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
|
US5270317A
(en)
|
1990-03-20 |
1993-12-14 |
Elf Sanofi |
N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
|
US5223516A
(en)
|
1990-03-22 |
1993-06-29 |
E. R. Squibb & Sons, Inc. |
3,3,3-trifluoro-2-mercaptomethyl-N-tetrazolyl substituted propanamides and method of using same
|
US5063245A
(en)
|
1990-03-28 |
1991-11-05 |
Nova Pharmaceutical Corporation |
Corticotropin-releasing factor antagonism compounds
|
EP0522038A4
(en)
|
1990-03-30 |
1993-05-26 |
Merck & Co. Inc. |
Substituted pyrimidines, pyrimidinones and pyridopyrimidines
|
JPH05505822A
(ja)
|
1990-03-30 |
1993-08-26 |
メルク・エンド・カムパニー・インコーポレーテツド |
ピラゾール類、イソキサゾール類及びイソチアゾール置換体
|
DE4010797A1
(de)
|
1990-04-04 |
1991-10-10 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
|
WO1991015206A1
(en)
|
1990-04-05 |
1991-10-17 |
E.I. Du Pont De Nemours And Company |
Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
|
US5175003A
(en)
|
1990-04-06 |
1992-12-29 |
Biosytes Usa, Inc. |
Dual mechanism controlled release system for drug dosage forms
|
CA2077897A1
(en)
|
1990-04-13 |
1991-10-14 |
Robert G. Franz |
Substituted benzimidazoles
|
EP0453210A3
(en)
|
1990-04-19 |
1993-01-13 |
Imperial Chemical Industries Plc |
Pyridine derivatives
|
US5196444A
(en)
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
DK0482208T3
(da)
|
1990-04-25 |
2000-09-18 |
Nissan Chemical Ind Ltd |
Pyridazinonderivat
|
US5703110A
(en)
|
1990-04-27 |
1997-12-30 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
US5642868A
(en)
|
1990-05-02 |
1997-07-01 |
The United States Of America As Represented By The Secretary Of The Navy |
Ceramic material
|
US5098920A
(en)
|
1990-05-04 |
1992-03-24 |
G. D. Searle & Co. |
1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
|
IL98087A
(en)
|
1990-05-04 |
1996-11-14 |
Perio Prod Ltd |
Preparation for dispensing drugs in the colon
|
GB9010394D0
(en)
|
1990-05-09 |
1990-06-27 |
Ici Plc |
Heterocyclic compounds
|
MY105344A
(en)
|
1990-05-16 |
1994-09-30 |
Byk Gulden Lomberg Chemische Fabrik |
New sulphonyl compounds
|
US5045540A
(en)
|
1990-05-25 |
1991-09-03 |
Warner-Lambert Co. |
Amino acid derivatives with angiotensin II antagonist properties
|
JPH05506443A
(ja)
|
1990-05-25 |
1993-09-22 |
ジー.ディー.サール アンド カンパニー |
心臓血管障害の治療用n―置換1,2,4―トリアゾロン化合物
|
JPH04235974A
(ja)
|
1990-06-08 |
1992-08-25 |
Roussel Uclaf |
新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
|
US5504078A
(en)
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
WO1991019715A1
(en)
|
1990-06-15 |
1991-12-26 |
G.D. Searle & Co. |
1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
CN1034934C
(zh)
|
1990-06-19 |
1997-05-21 |
明治制果株式会社 |
血管紧张素ii拮抗性吡啶衍生物的制备方法
|
GB9013750D0
(en)
|
1990-06-20 |
1990-08-08 |
Pfizer Ltd |
Therapeutic agents
|
CA2085584C
(en)
|
1990-06-22 |
2003-02-11 |
David John Carini |
Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
|
NZ238688A
(en)
|
1990-06-28 |
1992-05-26 |
Smithkline Beecham Corp |
Substituted histidines: pharmaceutical compositions, preparation and uses thereof
|
IE912114A1
(en)
|
1990-07-02 |
1992-01-15 |
Union Pharma Scient Appl |
Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present
|
IL98319A
(en)
|
1990-07-05 |
1997-04-15 |
Roussel Uclaf |
Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
|
US5053329A
(en)
|
1990-07-05 |
1991-10-01 |
Merck & Co., Inc. |
Process for preparation of novel angiotensin II antagonists
|
MA22668A1
(fr)
|
1990-07-10 |
1993-07-01 |
Smithkline Beecham Corp |
Procede de preparation d'oxamides .
|
US5137902A
(en)
|
1990-07-13 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
4-alkylimidazole derivatives and anti-hypertensive use thereof
|
CA2044806A1
(en)
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Purine derivatives
|
US5057522A
(en)
|
1990-07-19 |
1991-10-15 |
Merck & Co., Inc. |
Anti-hypersensitive N2-tetrazole-β-glucuronide analog
|
US5132216A
(en)
|
1990-07-19 |
1992-07-21 |
Merck & Co., Inc. |
Microbial transformation process for antihypertensive products
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
CA2047029A1
(en)
|
1990-07-19 |
1992-01-20 |
Shieh-Shung T. Chen |
Microbial transformation process for antihypertensive products
|
DE4023215A1
(de)
|
1990-07-21 |
1992-01-23 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
NZ239161A
(en)
|
1990-07-31 |
1994-01-26 |
Smithkline Beecham Corp |
Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
|
US5124455A
(en)
|
1990-08-08 |
1992-06-23 |
American Home Products Corporation |
Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
|
GB9017480D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Chemical process
|
GB9017482D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Manufacturing process
|
GB9017479D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Process
|
AU8534291A
(en)
|
1990-08-10 |
1992-03-02 |
G.D. Searle & Co. |
Renal-selective angiotensin ii antagonists for treatment of hypertension
|
EP0470543A1
(de)
|
1990-08-10 |
1992-02-12 |
Dr. Karl Thomae GmbH |
Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
|
US5066586A
(en)
|
1990-08-20 |
1991-11-19 |
Merck & Co., Inc. |
Process for preparation of novel angiotensin II antagonists
|
US5089626A
(en)
|
1990-08-23 |
1992-02-18 |
Merck & Co., Inc. |
Process for preparing an angiotensin II antagonist
|
US5217985A
(en)
|
1990-08-28 |
1993-06-08 |
G. D. Searle & Co. |
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
|
WO1992004343A1
(en)
|
1990-09-04 |
1992-03-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel tetrahydrobenzazole derivative
|
IE912956A1
(en)
|
1990-09-10 |
1992-03-11 |
Abbott Lab |
Angiotensin ii receptor antagonists
|
IL99372A0
(en)
|
1990-09-10 |
1992-08-18 |
Ciba Geigy Ag |
Azacyclic compounds
|
WO1992004059A1
(en)
|
1990-09-11 |
1992-03-19 |
Mectra Labs, Inc. |
Disposable lavage
|
US5140036A
(en)
|
1990-09-19 |
1992-08-18 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5210092A
(en)
|
1990-09-25 |
1993-05-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotensin ii antagonizing heterocyclic derivatives
|
US5242939A
(en)
|
1990-09-28 |
1993-09-07 |
Warner-Lambert Company |
Anilide derivatives with angiotensin ii antagonist properties
|
US5217877A
(en)
|
1990-09-28 |
1993-06-08 |
Bristol-Myers Squibb Company |
Process for the preparation of α-glucosidase inhibitor, pradimicin Q
|
US5091418A
(en)
|
1990-09-28 |
1992-02-25 |
Bristol-Myers Squibb Company |
Novel alpha-glucosidase inhibitor, pradimicin Q
|
US5126342A
(en)
|
1990-10-01 |
1992-06-30 |
Merck & Co., Inc. |
Imidazole angiotensin ii antagonists incorporating acidic functional groups
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
WO1992005784A1
(en)
|
1990-10-02 |
1992-04-16 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
|
US5260322A
(en)
|
1990-10-08 |
1993-11-09 |
Merck & Co., Inc. |
Angiotension II antagonists in the treatment of hyperuricemia
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
US5565473A
(en)
|
1990-10-12 |
1996-10-15 |
Merck Frosst Canada, Inc. |
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
|
DE59109027D1
(en)
|
1990-10-16 |
1998-08-13 |
Byk Gulden Lomberg Chem Fab |
Arylpyridazinone
|
CA2053148A1
(en)
|
1990-10-16 |
1992-04-17 |
Karnail Atwal |
Dihydropyrimidine derivatives
|
CA2053340C
(en)
|
1990-10-18 |
2002-04-02 |
Timothy P. Burkholder |
Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
|
US5130333A
(en)
|
1990-10-19 |
1992-07-14 |
E. R. Squibb & Sons, Inc. |
Method for treating type II diabetes employing a cholesterol lowering drug
|
AU9024591A
(en)
|
1990-10-25 |
1992-05-26 |
G.D. Searle & Co. |
Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
|
AU636066B2
(en)
|
1990-10-30 |
1993-04-08 |
Takeda Chemical Industries Ltd. |
Thienoimidazole derivatives, their production and use
|
PH31175A
(en)
|
1990-10-31 |
1998-03-20 |
Squibb & Sons Inc |
Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
|
US5087634A
(en)
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
DE4036645A1
(de)
|
1990-11-16 |
1992-05-21 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
|
GB9026006D0
(en)
|
1990-11-29 |
1991-01-16 |
Glaxo Group Ltd |
Chemical compounds
|
WO1992009278A1
(en)
|
1990-11-30 |
1992-06-11 |
Smithkline Beecham Corporation |
Substituted 5-aryl imidazoles
|
US5049565A
(en)
|
1990-12-07 |
1991-09-17 |
Merck & Co., Inc. |
Microbial transformation process for preparing anti-hypertensive products
|
CA2057089A1
(en)
|
1990-12-07 |
1992-06-08 |
Eric E. Allen |
Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
|
GB9027197D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027055D0
(en)
|
1990-12-13 |
1991-02-06 |
Sandoz Ltd |
Organic compounds
|
GB9027212D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027199D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027208D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027198D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027211D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027201D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
AU656551B2
(en)
|
1990-12-14 |
1995-02-09 |
Smithkline Beecham Corporation |
Angiotensin II receptor blocking compositions
|
GB9027209D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027200D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027210D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
AU657498B2
(en)
|
1990-12-14 |
1995-03-16 |
Novartis Ag |
Biphenylyl compounds
|
JPH04234389A
(ja)
|
1990-12-28 |
1992-08-24 |
Sapporo Breweries Ltd |
ナフチリジン誘導体及びそれを有効成分とする抗潰瘍剤
|
US5141931A
(en)
|
1991-01-03 |
1992-08-25 |
Sterling Winthrop Inc. |
5-Quinolinylpyridinones, cardiotonic compositions and methods
|
CA2058198A1
(en)
|
1991-01-04 |
1992-07-05 |
Adalbert Wagner |
Azole derivatives, process for their preparation, and their use
|
IE914572A1
(en)
|
1991-01-17 |
1992-07-29 |
Zeneca Ltd |
Chemical process
|
IE914573A1
(en)
|
1991-01-17 |
1992-07-29 |
Ici Plc |
Boron compounds
|
IE71647B1
(en)
|
1991-01-28 |
1997-02-26 |
Rhone Poulenc Rorer Ltd |
Benzamide derivatives
|
US5087702A
(en)
|
1991-01-30 |
1992-02-11 |
Merck & Co., Inc. |
Microbial transformation process for producing an antihypertensive product
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5124335A
(en)
|
1991-01-30 |
1992-06-23 |
Merck & Co., Inc. |
Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists
|
AT395853B
(de)
|
1991-01-31 |
1993-03-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
US5153347A
(en)
|
1991-01-31 |
1992-10-06 |
E. R. Squibb & Sons, Inc. |
Phosphonate, phosphinate derivatives useful as antihypertensive agents
|
WO1992013564A1
(en)
|
1991-02-06 |
1992-08-20 |
Schering Corporation |
Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
ATE156120T1
(de)
|
1991-02-07 |
1997-08-15 |
Roussel Uclaf |
Bizyklische stickstoffverbindungen, ihre herstellung, erhaltene zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
|
IL100555A
(en)
|
1991-02-07 |
2000-08-31 |
Hoechst Marion Roussel Inc |
N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
GB9102727D0
(en)
|
1991-02-08 |
1991-03-27 |
Ici Plc |
Pharmaceutical agent
|
GB9102804D0
(en)
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Heterocyclic derivatives
|
GB9102803D0
(en)
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Pyridine compounds
|
IE920175A1
(en)
|
1991-02-11 |
1992-08-12 |
Zeneca Ltd |
Nitrogen heterocycles
|
IL100917A0
(en)
|
1991-02-16 |
1992-11-15 |
Fisons Plc |
Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
|
FR2672892B1
(fr)
|
1991-02-20 |
1994-01-14 |
Synthelabo |
Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.
|
IE920540A1
(en)
|
1991-02-21 |
1992-08-26 |
Sankyo Co |
1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
|
US5104877A
(en)
|
1991-02-25 |
1992-04-14 |
Abbott Laboratories |
Psoriasis treatment
|
CA2061159A1
(en)
|
1991-02-26 |
1992-08-27 |
Michael A. Poss |
Imidazole and benzimidazole derivatives
|
US5187271A
(en)
|
1991-02-28 |
1993-02-16 |
G. D. Searle & Co. |
N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
|
FR2673427B1
(fr)
|
1991-03-01 |
1993-06-18 |
Sanofi Elf |
Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
|
US5202328A
(en)
|
1991-03-06 |
1993-04-13 |
Merck & Co., Inc. |
Substituted fused pyrimidinones
|
EP0503838A3
(en)
|
1991-03-08 |
1992-10-07 |
Merck & Co. Inc. |
Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
|
US5191086A
(en)
|
1991-03-19 |
1993-03-02 |
E.R. Squibb & Sons, Inc. |
Imidazole and benzimidazole derivatives
|
EP0505098A1
(en)
|
1991-03-19 |
1992-09-23 |
Merck & Co. Inc. |
Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists
|
US5196537A
(en)
|
1991-03-21 |
1993-03-23 |
G. D. Searle & Co. |
5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5187179A
(en)
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
HUT64023A
(en)
|
1991-03-22 |
1993-11-29 |
Sandoz Ag |
Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
|
IE73235B1
(en)
|
1991-03-25 |
1997-05-21 |
Akzo Nv |
4-aryl-thiazole or imidazole derivatives
|
AU1417092A
(en)
|
1991-03-25 |
1992-10-21 |
Glaxo Group Limited |
1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity
|
US5128327A
(en)
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
US5177074A
(en)
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
DE4110019C2
(de)
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
FR2674849B1
(fr)
|
1991-04-02 |
1994-12-23 |
Logeais Labor Jacques |
Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
|
US5157040A
(en)
|
1991-04-05 |
1992-10-20 |
Merck & Co., Inc. |
Substituted quinolines as angiotensin ii antagonists
|
US5164403A
(en)
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
US5151435A
(en)
|
1991-04-08 |
1992-09-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating an indole or dihydroindole
|
US5155117A
(en)
|
1991-04-12 |
1992-10-13 |
G. D. Searle & Co. |
1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
|
TW274551B
(zh)
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
US5190942A
(en)
|
1991-04-22 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
|
AU1574892A
(en)
|
1991-04-26 |
1992-12-21 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Novel pyridazines
|
US5252574A
(en)
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
CZ227093A3
(en)
|
1991-04-29 |
1994-03-16 |
Merck & Co Inc |
Mixture suitable for the preparation of tablets by direct moulding
|
GB9109246D0
(en)
|
1991-04-30 |
1991-06-19 |
Ici Plc |
Nitrogen derivatives
|
US5191084A
(en)
|
1991-05-01 |
1993-03-02 |
American Home Products Corporation |
Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
|
WO1992020662A1
(en)
|
1991-05-10 |
1992-11-26 |
Merck & Co., Inc. |
Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
|
US5162325A
(en)
|
1991-05-07 |
1992-11-10 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
US5198438A
(en)
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
JPH05112533A
(ja)
|
1991-05-08 |
1993-05-07 |
Upjohn Co:The |
イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
US5223501A
(en)
|
1991-05-10 |
1993-06-29 |
Merck & Co., Inc. |
Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
|
GB9110532D0
(en)
|
1991-05-15 |
1991-07-03 |
Smithkline Beecham Corp |
Chemical compounds
|
NZ242724A
(en)
|
1991-05-15 |
1994-09-27 |
Du Pont |
Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
|
EP0514192A1
(en)
|
1991-05-16 |
1992-11-19 |
Glaxo Group Limited |
Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups
|
MX9202300A
(es)
|
1991-05-16 |
1992-11-01 |
Glaxo Group Ltd |
Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
|
GB9110636D0
(en)
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
GB9110625D0
(en)
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
US5292726A
(en)
|
1991-05-22 |
1994-03-08 |
Merck & Co., Inc. |
N,N-diacylpiperazines
|
FR2676734B1
(fr)
|
1991-05-23 |
1995-05-19 |
Roussel Uclaf |
Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
AU1625192A
(en)
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
US5175164A
(en)
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
JPH05213884A
(ja)
|
1991-06-14 |
1993-08-24 |
Upjohn Co:The |
新規な4−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
FR2677984B1
(fr)
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5210211A
(en)
|
1991-06-21 |
1993-05-11 |
Warner-Lambert Company |
4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
|
GB9113628D0
(en)
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic derivatives
|
GB9113626D0
(en)
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic compounds
|
IL102183A
(en)
|
1991-06-27 |
1999-11-30 |
Takeda Chemical Industries Ltd |
The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
|
WO1993001177A1
(en)
|
1991-07-03 |
1993-01-21 |
Merck & Co., Inc. |
Substituted triazolinones
|
FR2678618B1
(fr)
|
1991-07-05 |
1993-11-05 |
Upsa Laboratoires |
Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
DE4123341A1
(de)
|
1991-07-15 |
1993-01-21 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
CH683149A5
(fr)
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
US5177097A
(en)
|
1991-07-24 |
1993-01-05 |
E. R. Squibb & Sons, Inc. |
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
|
GB9116039D0
(en)
|
1991-07-25 |
1991-09-11 |
Ucb Sa |
Substituted cyclopropylamino-1,3,5-triazines
|
WO1993003033A1
(en)
|
1991-07-26 |
1993-02-18 |
G. D. Searle & Co. |
CARBONATE-SUBSTITUTED IMIDAZO[4,5-d] PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
IT1250749B
(it)
|
1991-08-02 |
1995-04-21 |
Luso Farmaco Inst |
Composti eterociclici ad attivita' a ii antagonista
|
WO1993003040A1
(en)
|
1991-08-05 |
1993-02-18 |
Taisho Pharmaceutical Co., Ltd. |
Thienopyrimidin-4-one derivative
|
US5225401A
(en)
|
1991-08-12 |
1993-07-06 |
E. R. Squibb & Sons, Inc. |
Treatment of congestive heart failure
|
US5246944A
(en)
|
1991-08-13 |
1993-09-21 |
Merck & Co., Inc. |
Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
|
DE59208448D1
(de)
|
1991-08-15 |
1997-06-12 |
Ciba Geigy Ag |
N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten
|
JPH06510763A
(ja)
|
1991-08-19 |
1994-12-01 |
イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー |
アンジオテンシン2受容体遮断イミダゾリノン誘導体
|
AU2496492A
(en)
|
1991-08-19 |
1993-03-16 |
E.I. Du Pont De Nemours And Company |
Angiotensin ii receptor blocking imidazolinone derivatives
|
DE4129340A1
(de)
|
1991-09-04 |
1993-03-11 |
Merck Patent Gmbh |
1,2-dihydro-2-oxopyridine
|
WO1993005025A1
(en)
|
1991-09-06 |
1993-03-18 |
Glaxo Group Limited |
C-linked pyrazole derivatives
|
DE69216013T2
(de)
|
1991-09-10 |
1997-05-07 |
Tanabe Seiyaku Co |
Imidazoindolizinderivate mit Angiotensin-II Hemmwirkung
|
CA2077419C
(en)
|
1991-09-10 |
1998-08-25 |
Yasushi Honma |
Imidazopyridine derivatives and process for preparation thereof
|
TW300219B
(zh)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
US5256667A
(en)
|
1991-09-25 |
1993-10-26 |
Merck & Co., Inc. |
Quinazolinones and pyridopyrimidinones
|
ZA927211B
(en)
|
1991-09-27 |
1993-03-24 |
Merrell Dow Pharma |
Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
|
EP0534363B1
(en)
|
1991-09-27 |
1997-07-09 |
Merrell Pharmaceuticals Inc. |
Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
|
AU657793B2
(en)
|
1991-09-27 |
1995-03-23 |
Merrell Pharmaceuticals Inc. |
Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
DE4132633A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Cyclisch substituierte imidazolyl-propensaeurederivate
|
DE4132631A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Imidazolyl-propensaeurederivate
|
DE4132632A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Substituierte imidazolyl-propensaeurederivate
|
AT398202B
(de)
|
1991-10-04 |
1994-10-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
US5187159A
(en)
|
1991-10-07 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
|
CA2079982A1
(en)
|
1991-10-07 |
1993-04-08 |
Stephen E. De Laszlo |
Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists
|
JP3245165B2
(ja)
|
1991-10-09 |
2002-01-07 |
シンテックス(ユー・エス・エイ)・インコーポレイテッド |
ピリドピリダジノンおよびピリダジンチオン化合物
|
GB9121463D0
(en)
|
1991-10-10 |
1991-11-27 |
Smithkline Beecham Corp |
Medicament
|
GB9121727D0
(en)
|
1991-10-14 |
1991-11-27 |
Ici Plc |
Heterocyclic compounds
|
US5336677A
(en)
|
1991-10-24 |
1994-08-09 |
American Home Products Corporation |
Substituted aminopyrimidines as antihypertensives
|
US5234936A
(en)
|
1991-10-24 |
1993-08-10 |
American Home Products Corporation |
Pyrimidocycloalkanes as a ii antagonists
|
US5187168A
(en)
|
1991-10-24 |
1993-02-16 |
American Home Products Corporation |
Substituted quinazolines as angiotensin II antagonists
|
JPH06107661A
(ja)
|
1991-10-24 |
1994-04-19 |
Upjohn Co:The |
イミダゾール誘導体およびこれを有効成分とする医薬組成物
|
TW226375B
(zh)
|
1991-10-24 |
1994-07-11 |
American Home Prod |
|
US5149699A
(en)
|
1991-10-24 |
1992-09-22 |
American Home Products Corporation |
Substituted pyridopyrimidines useful as antgiotensin II antagonists
|
FR2683819B1
(fr)
|
1991-10-28 |
1994-02-11 |
Synthelabo |
Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
|
JP3221894B2
(ja)
|
1991-10-31 |
2001-10-22 |
ダウ・コ−ニング・コ−ポレ−ション |
分岐オルガノポリシロキサンの製造方法
|
US5252753A
(en)
|
1991-11-01 |
1993-10-12 |
Ortho Pharmaceutical Corporation |
Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
|
DE4221583A1
(de)
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
US5182288A
(en)
|
1991-11-13 |
1993-01-26 |
Ortho Pharmaceutical Corporation |
Substituted n-biphenylyl lactams
|
EP0543263A3
(en)
|
1991-11-16 |
1993-08-25 |
Dr. Karl Thomae Gmbh |
Benziimidazoles, pharmaceuticals containing them and process for their preparation
|
US5130439A
(en)
|
1991-11-18 |
1992-07-14 |
Lo Young S |
Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
|
WO1993012068A1
(en)
|
1991-12-11 |
1993-06-24 |
Brigham And Women's Hospital |
S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
|
US5212177A
(en)
|
1991-12-16 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Indole and benzimidazole-substituted dihydropyrimidine derivatives
|
CA2151741C
(en)
|
1991-12-30 |
2001-12-11 |
Alan Justice |
Methods of producing analgesia and enhancing opiate analgesia
|
US5824645A
(en)
|
1991-12-30 |
1998-10-20 |
Neurex Corporation |
Method of treating inflammation
|
WO1993015044A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as tnf and pde iv inhibitors
|
AU3481593A
(en)
|
1992-01-29 |
1993-09-01 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
GB9204808D0
(en)
|
1992-03-04 |
1992-04-15 |
Rhone Poulenc Rorer Ltd |
Novel compositions of matter
|
US5208235A
(en)
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole derivatives
|
US5208234A
(en)
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
US5264437A
(en)
|
1992-03-20 |
1993-11-23 |
Syntex (U.S.A.) Inc. |
Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
|
JP3199380B2
(ja)
|
1992-04-02 |
2001-08-20 |
スミスクライン・ビーチャム・コーポレイション |
化合物
|
WO1993019751A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
MX9301943A
(es)
|
1992-04-02 |
1994-08-31 |
Smithkline Beecham Corp |
Compuestos.
|
US5602173A
(en)
|
1992-04-02 |
1997-02-11 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
US5552397A
(en)
|
1992-05-18 |
1996-09-03 |
E. R. Squibb & Sons, Inc. |
Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
|
US5212195A
(en)
|
1992-05-13 |
1993-05-18 |
Syntex (U.S.A.) Inc. |
Substituted indole antagonists derivatives which are angiotensin II
|
EP0640086B1
(en)
|
1992-05-15 |
1999-08-04 |
Merrell Pharmaceuticals Inc. |
MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
|
RU2124503C1
(ru)
|
1992-05-18 |
1999-01-10 |
И.Р.Сквибб энд Санз, Инк. |
Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
|
GB9211268D0
(en)
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
DE69309030T2
(de)
|
1992-06-15 |
1997-09-25 |
Celltech Therapeutics Ltd |
Trisubstituierte phenylderivate als selektive phosphodiesterase iv inhibitoren
|
US5210204A
(en)
|
1992-06-16 |
1993-05-11 |
Warner-Lambert Company |
Biphenyl oxadiazoles and thiadiazoles as angiothesin II antagonists
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
US5969097A
(en)
|
1992-06-23 |
1999-10-19 |
G. D. Searle & Co. |
Human guanylin
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
4−アミノキナゾリン誘導体およびそれを含有する医薬品
|
NZ254881A
(en)
|
1992-07-28 |
1996-09-25 |
Rhone Poulenc Rorer Ltd |
Diether, dithioether or diether thioether derivatives of 1,2-dihydroxybenzenes substituted in position-4 by an (hetero)aryl-containing group;
|
US5185340A
(en)
|
1992-08-04 |
1993-02-09 |
American Home Products Corporation |
Pyrimidinyl arylalkyl ethers with antihypertensive activity
|
US5741803A
(en)
|
1992-09-05 |
1998-04-21 |
Smithkline Beecham Plc |
Substituted thiazolidinedionle derivatives
|
JP3559282B2
(ja)
|
1992-09-14 |
2004-08-25 |
ヴォルフ―ゲオルク フォルスマン |
ホスホジェステラーゼ ▲iv▼のインヒビターの新規使用
|
DK0661989T3
(da)
|
1992-09-21 |
1998-03-02 |
Upjohn Co |
Proteinsammensætninger med vedvarende frigivelse
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
US5504080A
(en)
|
1992-10-28 |
1996-04-02 |
Bristol-Myers Squibb Co. |
Benzo-fused lactams
|
BR9307570A
(pt)
|
1992-12-02 |
1999-05-25 |
Pfizer |
Diéteres de catecol como inibidores seletivos de pdeiv
|
US5578593A
(en)
|
1992-12-11 |
1996-11-26 |
Merck & Co., Inc. |
Spiro piperidines and homologs promote release of growth hormone
|
TW263495B
(zh)
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
JP3339730B2
(ja)
|
1992-12-24 |
2002-10-28 |
忠弘 大見 |
半導体装置
|
US5594016A
(en)
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
US5672659A
(en)
|
1993-01-06 |
1997-09-30 |
Kinerton Limited |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
|
ATE236655T1
(de)
|
1993-01-06 |
2003-04-15 |
Kinerton Ltd |
Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
US5358502A
(en)
|
1993-02-25 |
1994-10-25 |
Pfizer Inc |
PH-triggered osmotic bursting delivery devices
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
EP0688429B1
(en)
|
1993-03-09 |
1998-02-11 |
Epic Therapeutics, Inc.. |
Macromolecular microparticles and methods of production
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
US5459151A
(en)
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
GB9309324D0
(en)
|
1993-05-06 |
1993-06-16 |
Bayer Ag |
Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
|
US6191105B1
(en)
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
GB9311282D0
(en)
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
US5508272A
(en)
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
JPH0710875A
(ja)
|
1993-06-21 |
1995-01-13 |
Green Cross Corp:The |
選択的ホスホジエステラーゼiv阻害剤
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
KR100331255B1
(ko)
|
1993-07-02 |
2002-10-25 |
빅굴덴 롬베르그 케미쉐 화부리크 게엠베하 |
플루오로알콕시-치환된벤즈아미드및시클릭뉴클레오티드포스포디에스테라아제억제제로서의그의용도
|
BR9406946A
(pt)
|
1993-07-06 |
1996-08-06 |
Pfizer |
Tetra-hidro-pirazolpiridinas bicíclicas
|
US5362727A
(en)
|
1993-07-26 |
1994-11-08 |
Bristol-Myers Squibb |
Substituted azepino[2,1-a]isoquinoline compounds
|
ES2176251T3
(es)
|
1993-07-28 |
2002-12-01 |
Aventis Pharma Ltd |
Compuestos utilizados como inhibidores de pde iv y del factor de necrosis tumoral(tnf).
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
EP0714293A4
(en)
|
1993-07-30 |
1999-04-07 |
Smithkline Beecham Corp |
3-CYANO-3- (3,4-DISUBSTITUTED) PHENYLCYCLOHEXYL-1-CARBOXYLATE
|
JPH09502170A
(ja)
|
1993-08-19 |
1997-03-04 |
スミスクライン・ビーチャム・コーポレイション |
フェネチルアミン化合物
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
WO1995009623A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Anti-allergic, anti-inflammatory compounds, compositions and uses
|
EP0727990B1
(en)
|
1993-10-01 |
2001-06-13 |
Smithkline Beecham Corporation |
Compounds, compositions and treatment of allergies and inflammation
|
JPH09503503A
(ja)
|
1993-10-01 |
1997-04-08 |
スミスクライン・ビーチャム・コーポレイション |
化合物、組成物ならびにアレルギーおよび炎症の治療
|
WO1995009836A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Cyanocyclohexane compounds, compositions, and uses thereof
|
ES2216004T3
(es)
|
1993-10-26 |
2004-10-16 |
Thomas Jefferson University |
Composiciones que se unen especificamente a celulas cancerosas colorectales y procedimientos de uso de las mismas.
|
US5518888A
(en)
|
1993-10-26 |
1996-05-21 |
Thomas Jefferson University |
ST receptor binding compounds and methods of using the same
|
US5879656A
(en)
|
1993-10-26 |
1999-03-09 |
Thomas Jefferson University |
Methods of treating metastatic colorectal cancer with ST receptor binding compounds
|
US5601990A
(en)
|
1994-09-13 |
1997-02-11 |
Thomas Jefferson University |
Methods of diagnosing colorectal tumors and metastasis thereof
|
US5489670A
(en)
|
1993-10-29 |
1996-02-06 |
G. D. Searle & Co. |
Human uroguanylin
|
GB9322828D0
(en)
|
1993-11-05 |
1993-12-22 |
Sandoz Ltd |
Organic compounds
|
WO1995013801A1
(en)
|
1993-11-17 |
1995-05-26 |
Commonwealth Scientific And Industrial Research Organisation |
Fatty acid delivery system
|
US5525723A
(en)
|
1993-11-18 |
1996-06-11 |
Bristol-Myers Squibb Co. |
Compounds containing a fused multiple ring lactam
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
HUT76784A
(en)
|
1993-11-26 |
1997-11-28 |
Pfizer |
Antiinflammatory isoxazoline compounds and pharmaceutical compositions containing them
|
ES2139754T3
(es)
|
1993-11-26 |
2000-02-16 |
Pfizer |
3-fenil-2-isoxazolinas como agentes antiinflamatorios.
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
GB9326699D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
ATE260911T1
(de)
|
1993-12-22 |
2004-03-15 |
Celltech R&D Ltd |
Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
|
US5508300A
(en)
|
1994-01-14 |
1996-04-16 |
Pfizer Inc. |
Dihydro pyrazolopyrroles, compositions and use
|
JP2928079B2
(ja)
|
1994-02-14 |
1999-07-28 |
永信薬品工業股▲ふん▼有限公司 |
1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
|
AU692839B2
(en)
|
1994-02-17 |
1998-06-18 |
American Home Products Corporation |
Substituted biphenyl derivatives as phosphodiesterase inhibitors
|
CA2143143A1
(en)
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
GB9404706D0
(en)
|
1994-03-11 |
1994-04-27 |
Smithkline Beecham Corp |
Compounds
|
US5952314A
(en)
|
1994-04-01 |
1999-09-14 |
Demichele; Stephen Joseph |
Nutritional product for a person having ulcerative colitis
|
WO1995027692A1
(en)
|
1994-04-08 |
1995-10-19 |
Smithkline Beecham Corporation |
Subtituted biphenyl tnf inhibitors
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
ATE255413T1
(de)
|
1994-04-21 |
2003-12-15 |
Schering Ag |
Pde iv-inhibitoren zur behandlung der multiplen sklerose
|
ES2188657T3
(es)
|
1994-04-22 |
2003-07-01 |
Yamanouchi Pharma Co Ltd |
Sistema para la liberacion especifica en el colon de un farmaco.
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
HRP950288A2
(en)
|
1994-05-31 |
1997-08-31 |
Bayer Ag |
Oxalylamino-benzofuran- and benzothienyl-derivatives
|
EP0685475B1
(en)
|
1994-05-31 |
1999-01-13 |
Bayer Ag |
Amino-benzofuryl-and thienyl-derivatives
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
GB9412383D0
(en)
|
1994-06-21 |
1994-08-10 |
Celltech Ltd |
Chemical compound
|
DE69526790T2
(de)
|
1994-06-24 |
2003-03-06 |
Euroceltique S.A., Luxemburg/Luxembourg |
Verbindungen zur hemmung von phosphodiesrerase iv
|
US5466697A
(en)
|
1994-07-13 |
1995-11-14 |
Syntex (U.S.A.) Inc. |
8-phenyl-1,6-naphthyridin-5-ones
|
JP4146894B2
(ja)
|
1994-07-22 |
2008-09-10 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジヒドロベンゾフラン
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
US5491134A
(en)
|
1994-09-16 |
1996-02-13 |
Bristol-Myers Squibb Company |
Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
|
CA2202273A1
(en)
|
1994-10-12 |
1996-04-25 |
David J. Cavalla |
Novel benzoxazoles
|
AU692977B2
(en)
|
1994-11-07 |
1998-06-18 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
US5902726A
(en)
|
1994-12-23 |
1999-05-11 |
Glaxo Wellcome Inc. |
Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
|
US5843866A
(en)
|
1994-12-30 |
1998-12-01 |
Hampshire Chemical Corp. |
Pesticidal compositions comprising solutions of polyurea and/or polyurethane
|
DE19501481A1
(de)
*
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,8-Disubstituierte Chinazolinone
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
CA2211656A1
(en)
|
1995-01-31 |
1996-08-08 |
Margret B. Basinski |
Anti-obesity proteins
|
WO1996023515A1
(en)
|
1995-01-31 |
1996-08-08 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
US5612052A
(en)
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
TWI238064B
(en)
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
DK1336409T3
(da)
|
1995-06-27 |
2007-08-13 |
Eisai R&D Man Co Ltd |
Sammensætninger af formuleringer til fremstilling af analgesimidler og til hæmning af fremadskridende neuropatiske smertelidelser
|
US6054429A
(en)
|
1996-03-08 |
2000-04-25 |
Elan Pharmaceuticals, Inc. |
Epidural method of producing analgesia
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
US5877224A
(en)
|
1995-07-28 |
1999-03-02 |
Rutgers, The State University Of New Jersey |
Polymeric drug formulations
|
WO1997010813A1
(en)
|
1995-09-18 |
1997-03-27 |
Ligand Pharmaceuticals Incorporated |
Ppar gamma antagonists for treating obesity
|
AUPN634595A0
(en)
*
|
1995-11-03 |
1995-11-30 |
Borody, Thomas Julius |
Improved method for colonic evacuation
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
GB9524104D0
(en)
|
1995-11-24 |
1996-01-24 |
Smithkline Beecham Spa |
Novel compounds
|
EP0876347B1
(en)
|
1995-11-24 |
2005-03-02 |
GlaxoSmithKline S.p.A. |
Quinoline derivatives
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
WO1997019682A1
(en)
|
1995-12-01 |
1997-06-05 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
AU7692896A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Quinazolin-2,4-diazirines as NPY receptor antagonist
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
WO1997020821A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl derivatives
|
WO1997020820A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl compounds
|
DE69636677D1
(de)
|
1995-12-13 |
2006-12-14 |
Univ California |
Kristalle der mit einem Ligand komplexierten Ligandenbindedomäne des Schilddrüsenhormonrezeptors
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
EP0888278B1
(en)
|
1996-02-02 |
2003-07-23 |
Merck & Co., Inc. |
Antidiabetic agents
|
ES2241036T3
(es)
|
1996-02-02 |
2005-10-16 |
MERCK & CO., INC. |
Procedimiento de tratamiento de diabetes y estados patologicos asociados.
|
ES2194179T3
(es)
|
1996-02-02 |
2003-11-16 |
Merck & Co Inc |
Derivados heterociclicos como agentes antidiabeticos y antiobesidad.
|
JP2002515865A
(ja)
|
1996-02-02 |
2002-05-28 |
メルク エンド カンパニー インコーポレーテッド |
抗糖尿病薬
|
AU1618697A
(en)
|
1996-02-06 |
1997-08-28 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
RU2165942C2
(ru)
|
1996-04-23 |
2001-04-27 |
Кинертон Лимитид |
Биоразрушаемый сложный полиэфир и способ его получения (варианты)
|
JP2000511903A
(ja)
|
1996-06-07 |
2000-09-12 |
メルク エンド カンパニー インコーポレーテッド |
糖尿病および肥満の治療のための選択性β▲下3▼作動薬としてのオキサジアゾール・ベンゼンスルホンアミド
|
AU4050797A
(en)
|
1996-08-02 |
1998-02-25 |
Ligand Pharmaceuticals Incorporated |
Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
|
US5861398A
(en)
|
1996-08-26 |
1999-01-19 |
Alanex Corporation |
Benzoperimidine-carboxylic acids and derivatives thereof
|
US6403130B2
(en)
|
1996-09-09 |
2002-06-11 |
Kiwitech Limited |
High-methoxyl pectin-acid casein polymer and process of making
|
AU4176997A
(en)
|
1996-09-16 |
1998-04-02 |
Warner-Lambert Company |
3-alkyl-3-phenyl-piperidines
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
HRP970493A2
(en)
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
WO1998027063A1
(fr)
|
1996-12-16 |
1998-06-25 |
Banyu Pharmaceutical Co., Ltd. |
Derives d'aminopyrazole
|
ES2213892T3
(es)
|
1997-01-21 |
2004-09-01 |
Smithkline Beecham Corporation |
Nuevos moduladores del receptor de canabinoides.
|
SK100099A3
(en)
|
1997-01-28 |
2000-05-16 |
Merck & Co Inc |
Thiazole benzenesulfonamides as 'beta'3 agonists for the treatment of diabetes and obesity
|
CN1246845A
(zh)
|
1997-02-04 |
2000-03-08 |
纳幕尔杜邦公司 |
杀菌的羧酰胺
|
US6589750B2
(en)
|
1997-02-20 |
2003-07-08 |
Institut Pasteur |
Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
|
DK0966436T3
(da)
|
1997-02-21 |
2003-03-31 |
Bayer Ag |
Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
|
US6153632A
(en)
|
1997-02-24 |
2000-11-28 |
Rieveley; Robert B. |
Method and composition for the treatment of diabetes
|
US5893985A
(en)
|
1997-03-14 |
1999-04-13 |
The Lincoln Electric Company |
Plasma arc torch
|
WO1998041519A1
(en)
|
1997-03-18 |
1998-09-24 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor agonists
|
JPH10324642A
(ja)
|
1997-03-26 |
1998-12-08 |
Meiji Seika Kaisha Ltd |
大腸送達性構造体
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
DE69812096T2
(de)
|
1997-04-23 |
2003-10-30 |
Banyu Pharmaceutical Co., Ltd. |
Neuropeptid y rezeptorantagonisten
|
NZ329807A
(en)
|
1997-04-23 |
2000-07-28 |
Pfizer |
NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
|
JP2001523245A
(ja)
|
1997-04-24 |
2001-11-20 |
メルク シヤープ エンド ドーム リミテツド |
肥満を治療するためのnk−1受容体拮抗薬およびssriの使用
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
JP2001516765A
(ja)
|
1997-09-12 |
2001-10-02 |
ヴォルフ ゲオルグ フォースマン |
真性糖尿病及び肥満の治療のための組成物
|
DE19744027A1
(de)
|
1997-10-06 |
1999-04-08 |
Hoechst Marion Roussel De Gmbh |
Substituierte Pyrazolo[3,4-b]pyridine, ihre Herstellung und Verwendung in Arzneimitteln
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
EP1124807A1
(en)
|
1997-10-27 |
2001-08-22 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
US6203513B1
(en)
|
1997-11-20 |
2001-03-20 |
Optonol Ltd. |
Flow regulating implant, method of manufacture, and delivery device
|
AU1887999A
(en)
|
1998-01-29 |
1999-08-16 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
JP2002501889A
(ja)
|
1998-02-02 |
2002-01-22 |
トラスティーズ オブ タフツ カレッジ |
グルコース代謝を調節する方法、およびそれに関連する試薬
|
JP2002506075A
(ja)
|
1998-03-09 |
2002-02-26 |
フォンダテッヒ・ベネルクス・ナムローゼ・フェンノートシャップ |
セリンペプチダーゼ調節剤
|
EP1068207A1
(en)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
|
US20010006972A1
(en)
|
1998-04-21 |
2001-07-05 |
Stephen A. Williams |
Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
|
AU759313B2
(en)
|
1998-04-29 |
2003-04-10 |
Ortho-Mcneil Pharmaceutical, Inc. |
N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
|
CN1308622A
(zh)
|
1998-05-12 |
2001-08-15 |
美国家用产品公司 |
用于治疗胰岛素抗性和高血糖的联苯基氧代-乙酸
|
WO1999058521A1
(en)
|
1998-05-12 |
1999-11-18 |
American Home Products Corporation |
11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
|
JP2002514639A
(ja)
|
1998-05-12 |
2002-05-21 |
アメリカン・ホーム・プロダクツ・コーポレイション |
ナフト[2,3−b]ヘテロアリー−4−イル誘導体
|
AU756337B2
(en)
|
1998-05-12 |
2003-01-09 |
Wyeth |
Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
|
NZ504106A
(en)
|
1998-05-27 |
2003-02-28 |
Dr |
Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
AU742425B2
(en)
|
1998-06-11 |
2002-01-03 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
DE19830375A1
(de)
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
DE69926764T2
(de)
|
1998-09-10 |
2006-06-29 |
Millennium Pharmaceuticals, Inc., Cambridge |
Methoden zur bestimmung von komponenten zur modulation des körpergewichts
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
DE19844547C2
(de)
|
1998-09-29 |
2002-11-07 |
Aventis Pharma Gmbh |
Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US7417038B1
(en)
|
1998-10-15 |
2008-08-26 |
Imperial Innovations Limited |
Methods of treating cachexia
|
EP1123292A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
WO2000023417A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
EP1123267A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
DE69929235T2
(de)
|
1998-11-10 |
2006-08-24 |
Merck & Co., Inc. |
Spiro-indole als y5-rezeptor antagonisten
|
US6235782B1
(en)
|
1998-11-12 |
2001-05-22 |
Rifat Pamukcu |
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
|
IT1304152B1
(it)
|
1998-12-10 |
2001-03-08 |
Mediolanum Farmaceutici Srl |
Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
DE19903087A1
(de)
|
1999-01-27 |
2000-08-10 |
Forssmann Wolf Georg |
Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
CZ20013278A3
(cs)
|
1999-03-19 |
2002-07-17 |
Knoll Gmbh |
Pouľití sloučeniny a farmaceutická kompozice ji obsahující
|
CA2371940C
(en)
|
1999-03-31 |
2008-07-15 |
Janssen Pharmaceutica N.V. |
Pregelatinized starch in a controlled release formulation
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
JP2002543067A
(ja)
|
1999-04-22 |
2002-12-17 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的なnpy(y5)のアンタゴニスト
|
US6218408B1
(en)
|
1999-06-30 |
2001-04-17 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
CA2373035A1
(en)
|
1999-05-05 |
2000-11-16 |
Scott Dax |
3a,4,5,9b-tetrahydro-1h-benz[e]indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders
|
ATE306481T1
(de)
|
1999-05-12 |
2005-10-15 |
Ortho Mcneil Pharm Inc |
Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
|
CA2377369A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
GB9913782D0
(en)
|
1999-06-14 |
1999-08-11 |
Smithkline Beecham Plc |
Novel compounds
|
NZ516031A
(en)
|
1999-06-15 |
2003-10-31 |
Bristol Myers Squibb Pharma Co |
Substituted heterocycle fused gamma-carbolines
|
US6207699B1
(en)
|
1999-06-18 |
2001-03-27 |
Richard Brian Rothman |
Pharmaceutical combinations for treating obesity and food craving
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US6645525B1
(en)
|
1999-06-23 |
2003-11-11 |
Sedum Laboratories, Inc. |
Ionically formulated biomolecule microcarriers
|
AU6154700A
(en)
|
1999-06-23 |
2001-01-31 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
|
EP1194421B1
(en)
|
1999-06-30 |
2005-10-12 |
H. Lundbeck A/S |
Selective npy (y5) antagonists
|
WO2001000579A1
(en)
|
1999-06-30 |
2001-01-04 |
Tularik Inc. |
COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
ATE306482T1
(de)
|
1999-07-28 |
2005-10-15 |
Ortho Mcneil Pharm Inc |
Amine and amide als ligande für den neuropeptid-y y5 rezeptor, und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
|
EP1078632A1
(en)
|
1999-08-16 |
2001-02-28 |
Sanofi-Synthelabo |
Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
|
DK1204429T3
(da)
|
1999-08-18 |
2004-03-08 |
Sod Conseils Rech Applic |
Præparat til forsinket frigivelse af et peptid
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
EP1206262A4
(en)
|
1999-08-26 |
2003-01-02 |
Bristol Myers Squibb Co |
Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES
|
SE9903291D0
(sv)
|
1999-09-15 |
1999-09-15 |
Astra Ab |
New process
|
AU7315800A
(en)
|
1999-09-20 |
2001-04-24 |
Takeda Chemical Industries Ltd. |
Mch antagonists
|
CA2379633C
(en)
|
1999-09-30 |
2006-06-20 |
Neurogen Corporation |
Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
CA2379640C
(en)
|
1999-09-30 |
2006-11-28 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
KR20020047198A
(ko)
|
1999-09-30 |
2002-06-21 |
해피 페너 ; 해리 에이치. 페너 2세 |
특정 알킬렌 디아민-치환된피라졸로[1,5-a]-1,5-피리미딘 및피라졸로[1,5-a]-1,3,5-트리아진
|
AU7802700A
(en)
|
1999-10-06 |
2001-05-10 |
Melacure Therapeutics Ab |
Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase
|
WO2001025266A1
(en)
|
1999-10-06 |
2001-04-12 |
Pharmacia Corporation |
Uroguanylin as an intestinal cancer inhibiting agent
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
PL355289A1
(en)
|
1999-10-13 |
2004-04-05 |
Pfizer Products Inc. |
Biaryl ether derivatives useful as monoamine reuptake inhibitors
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
EP1225897B1
(en)
|
1999-11-01 |
2004-09-08 |
RHODES, John |
Composition for treatment of constipation and irritable bowel syndrome
|
AU777569B2
(en)
|
1999-11-05 |
2004-10-21 |
Sanofi-Aventis Deutschland Gmbh |
Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
|
MXPA02006016A
(es)
|
1999-12-16 |
2002-12-05 |
Schering Corp |
Imidazoles sustituidos, antagonistas de los receptores y5 del neuropeptido y.
|
FR2802817B1
(fr)
|
1999-12-23 |
2002-10-11 |
Centre Nat Rech Scient |
Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
|
CA2396037A1
(en)
|
1999-12-31 |
2001-07-12 |
Rutgers, The State University |
Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
|
US7521061B2
(en)
|
1999-12-31 |
2009-04-21 |
Rutgers, The State University Of New Jersey |
Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
|
CA2395892C
(en)
|
1999-12-31 |
2014-06-03 |
Rutgers, The State University |
Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
|
US20030064105A1
(en)
|
2000-08-25 |
2003-04-03 |
Myung-Jin Kim |
Lipophilic-coated microparticle containing a protein drug and formulation comprising same
|
AUPQ514600A0
(en)
|
2000-01-18 |
2000-02-10 |
James Cook University |
Brain injury treatment
|
AU2001229491A1
(en)
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
AU2001214778A1
(en)
|
2000-01-26 |
2001-08-07 |
Warner Lambert Company |
Method for preventing or treating postoperative ileus
|
WO2001056592A1
(en)
|
2000-02-01 |
2001-08-09 |
Novo Nordisk A/S |
Use of compounds for the regulation of food intake
|
JP2004502642A
(ja)
|
2000-02-11 |
2004-01-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
AU2001234128B2
(en)
|
2000-02-22 |
2004-11-11 |
Banyu Pharmaceutical Co., Ltd. |
Novel imidazoline compounds
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
PL357547A1
(en)
|
2000-02-23 |
2004-07-26 |
Aventis Pharma Deutschland Gmbh |
8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
AU2001244136B2
(en)
|
2000-02-26 |
2005-04-14 |
Sanofi-Aventis Deutschland Gmbh |
8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, method for production thereof and use thereof as medicament
|
WO2001064212A1
(en)
|
2000-03-01 |
2001-09-07 |
University College London |
Modulators of the endocannabinoid uptake and of the vallinoid receptors
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
CN100393703C
(zh)
|
2000-03-14 |
2008-06-11 |
埃科特莱茵药品有限公司 |
1,2,3,4-四氢异喹啉的衍生物
|
WO2001070700A1
(en)
|
2000-03-23 |
2001-09-27 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
US6458790B2
(en)
|
2000-03-23 |
2002-10-01 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin receptor agonists
|
JP2003527444A
(ja)
|
2000-03-23 |
2003-09-16 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
PH12001000675B1
(en)
|
2000-04-04 |
2009-09-22 |
Australian Food Ind Sci Ct |
Encapsulation of food ingredients
|
EP1142886A1
(en)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinnin, a process for its production and its use as a pharmaceutical
|
AU4671101A
(en)
|
2000-04-10 |
2001-10-23 |
Malcolm R. Law |
Formulation for the prevention of cardiovascular disease
|
JP2004501076A
(ja)
|
2000-04-17 |
2004-01-15 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、それらの製造及び使用
|
CN1630532A
(zh)
|
2000-04-19 |
2005-06-22 |
约翰斯霍普金斯大学 |
预防和治疗胃肠疾病的方法
|
ATE479429T1
(de)
|
2000-04-28 |
2010-09-15 |
Takeda Pharmaceutical |
Antagonisten des melanin-konzentrierenden hormons
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
WO2001085173A1
(en)
|
2000-05-10 |
2001-11-15 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
BR0110638A
(pt)
|
2000-05-11 |
2003-03-25 |
Bristol Myers Squibb Co |
Análogos de tetraidroisoquinolina úteis como secretagogos de hormÈnio do crescimento
|
AU2001256733A1
(en)
|
2000-05-16 |
2001-11-26 |
Takeda Chemical Industries Ltd. |
Melanin-concentrating hormone antagonist
|
WO2001087335A2
(en)
|
2000-05-17 |
2001-11-22 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
CA2410597A1
(en)
|
2000-05-30 |
2001-12-06 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
PL359822A1
(en)
|
2000-06-15 |
2004-09-06 |
Schering Corporation |
Thrombin receptor antagonists
|
EP1289955B1
(en)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
EP1299362A4
(en)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
CA2414198A1
(en)
|
2000-07-06 |
2002-01-17 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
DK1303509T3
(da)
|
2000-07-13 |
2013-01-02 |
Lilly Co Eli |
Beta3 adrenerge agonister
|
US20020187938A1
(en)
|
2000-07-24 |
2002-12-12 |
Romano Deghenghi |
Ghrelin antagonists
|
JP4180365B2
(ja)
|
2000-07-31 |
2008-11-12 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピペラジン誘導体
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
JP2004506685A
(ja)
|
2000-08-21 |
2004-03-04 |
グリアテツク・インコーポレイテツド |
食欲の制御と肥満の治療のためのヒスタミンh3受容体逆アゴニストの使用
|
US6680340B2
(en)
|
2000-08-21 |
2004-01-20 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
JP2004531201A
(ja)
|
2000-08-22 |
2004-10-14 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトプロテアーゼ及び該プロテアーゼをコードするポリヌクレオチド
|
US6767915B2
(en)
|
2000-08-23 |
2004-07-27 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin receptor agonists
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
MXPA03002263A
(es)
|
2000-09-14 |
2003-06-24 |
Schering Corp |
Antagonistas de receptor de neuropeptido y y5 de urea sustituidos.
|
WO2002026743A1
(en)
|
2000-09-26 |
2002-04-04 |
Biovitrum Ab |
Novel pyridazine compounds for the treatment of diabetes
|
WO2002026707A1
(en)
|
2000-09-26 |
2002-04-04 |
Biovitrum Ab |
Novel compounds
|
JP2002114768A
(ja)
|
2000-10-11 |
2002-04-16 |
Japan Tobacco Inc |
2−(2,5−ジハロゲン−3,4−ジヒドロキシフェニル)アゾール化合物及びそれを含有してなる医薬組成物
|
GB0025208D0
(en)
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
TR200402046T4
(tr)
|
2000-10-13 |
2004-10-21 |
Eli Lilly And Company |
Büyüme hormonu salgılanmasını uyarıcı maddeler olarak ikameli dipeptitler.
|
AU2002221670B2
(en)
|
2000-10-16 |
2006-11-02 |
F. Hoffmann-La Roche Ag |
Indoline derivatives and their use as 5-HT2 receptor ligands
|
CZ20031012A3
(en)
|
2000-10-20 |
2004-04-14 |
Pfizer Products Inc. |
Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
|
AU2002227170A1
(en)
|
2000-11-03 |
2002-05-15 |
Wyeth |
Cycloalkyl(b)(1,4)diazepino(6,7,1-hi)indoles and derivatives
|
CA2427800A1
(en)
|
2000-11-03 |
2002-05-10 |
The Regents Of The University Of California |
Prokineticin polypeptides, related compositions and methods
|
DE10055857A1
(de)
|
2000-11-10 |
2002-08-22 |
Creative Peptides Sweden Ab Dj |
Neue pharmazeutische Depotformulierung
|
DE60120748T2
(de)
|
2000-11-10 |
2007-05-16 |
Eli Lilly And Co., Indianapolis |
3-substituierte oxindolderivate als beta-3-agonisten
|
JP4204315B2
(ja)
|
2000-11-20 |
2009-01-07 |
ビオヴィトルム・アクチボラゲット(プブリクト) |
セロトニン5−ht2レセプターのアンタゴニストとしてのピペラジニルピラジン化合物
|
AU2426602A
(en)
|
2000-11-20 |
2002-05-27 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
|
EP1353918B1
(en)
|
2000-11-28 |
2005-01-12 |
Smithkline Beecham Plc |
Morpholine derivatives as antagonists of orexin receptors
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
DE60115092T2
(de)
|
2000-12-12 |
2006-03-30 |
Neurogen Corp., Brandford |
Spiro[isobenzofuran-1,4'-piperidin]-3-one und 3h-spiroisobenzofuran-1,4'-piperidine
|
AU2002230843B8
(en)
|
2000-12-14 |
2007-05-17 |
Amylin Pharmaceuticals, Llc |
Peptide YY and peptide YY agonists for treatment of metabolic disorders
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
AR035520A1
(es)
|
2000-12-21 |
2004-06-02 |
Schering Corp |
Compuestos heteroarilo urea que son neuropeptidos y antagonistas de los receptores y5 del neuropeptido y, composiciones farmaceuticas, un proceso para su preparacion, uso de dichos compuestos y composiciones para la manufactura de medicamentos
|
CN1273451C
(zh)
|
2000-12-22 |
2006-09-06 |
先灵公司 |
哌啶mch拮抗剂及其治疗肥胖症的用途
|
MXPA03005648A
(es)
|
2000-12-22 |
2003-10-06 |
Astrazeneca Ab |
Derivados de carbazol y su uso, como ligandos de receptor del neuropeptido y5.
|
PT1216707E
(pt)
|
2000-12-22 |
2005-06-30 |
Pasteur Institut |
Novas utilizacoes terapeuticas para um smr-1-peptideo
|
JP4088412B2
(ja)
|
2000-12-26 |
2008-05-21 |
トヨタ自動車株式会社 |
内燃機関の空燃比制御装置
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
ATE369368T1
(de)
|
2000-12-27 |
2007-08-15 |
Hoffmann La Roche |
Indolderivate und deren verwendung als 5-ht2b- und 5-ht2c-rezeptorliganden
|
JP2004521117A
(ja)
|
2001-01-23 |
2004-07-15 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニストとしての置換ピペリジン/ピペラジン
|
EP1358163A1
(en)
|
2001-01-23 |
2003-11-05 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
US7291619B2
(en)
|
2001-01-23 |
2007-11-06 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
WO2002058672A2
(en)
|
2001-01-26 |
2002-08-01 |
Debio Recherche Pharmaceutique S.A. |
Microparticles of biodegradable polymer encapsulating a biologically active substance
|
CZ20032031A3
(cs)
|
2001-01-26 |
2003-12-17 |
Schering Corporation |
Farmaceutický prostředek
|
MXPA03006918A
(es)
|
2001-02-02 |
2004-05-24 |
Takeda Chemical Industries Ltd |
Compuestos heterociclicos fusionados.
|
BR0206847A
(pt)
|
2001-02-02 |
2004-02-25 |
Pfizer |
Tratamento do diabete melito
|
AU2002235520A1
(en)
|
2001-02-02 |
2002-08-19 |
Pharmacia Corporation |
Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
|
EP1363914A1
(en)
|
2001-02-05 |
2003-11-26 |
Dr. Reddy's Laboratories Ltd. |
Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
|
IL157253A0
(en)
|
2001-02-28 |
2004-02-19 |
Merck & Co Inc |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
DE60232238D1
(de)
|
2001-02-28 |
2009-06-18 |
Merck & Co Inc |
Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten
|
WO2002068387A2
(en)
|
2001-02-28 |
2002-09-06 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
EP1372661B1
(en)
|
2001-02-28 |
2006-05-17 |
SmithKline Beecham Corporation |
Glycol derivatves of xanthines for treating irritable bowel syndrome
|
GB0105772D0
(en)
|
2001-03-08 |
2001-04-25 |
Sterix Ltd |
Use
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
AU2002244295B2
(en)
|
2001-03-13 |
2006-02-09 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms containing glucocorticosteroid
|
EP1367968A4
(en)
|
2001-03-16 |
2006-12-13 |
Glaukos Corp |
APPLICATOR AND METHOD FOR SETTING A TRABECULAR SHUNT FOR GLUCKOM TREATMENT
|
AU2002258563A1
(en)
|
2001-03-19 |
2002-10-03 |
Praecis Pharmaceuticals Incorporated |
Pharmaceutical formulations for sustained release
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
IL157456A0
(en)
|
2001-03-21 |
2004-03-28 |
Pharmacopeia Inc Pharmacopeia |
Aryl and biaryl compounds having mch modulatory activity
|
WO2002076949A1
(en)
|
2001-03-22 |
2002-10-03 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
CA2795396C
(en)
|
2001-03-29 |
2015-11-17 |
Synergy Pharmaceuticals, Inc. |
Guanylate cyclase receptor agonists for stimulating water transport in the gastrointestinal tract to treat tissue inflammation
|
WO2001074782A1
(en)
|
2001-03-29 |
2001-10-11 |
Molecular Design International, Inc. |
β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
|
GB0108631D0
(en)
|
2001-04-05 |
2001-05-30 |
Melacure Therapeutics Ab |
Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
WO2002083134A1
(en)
|
2001-04-12 |
2002-10-24 |
Pharmacopeia, Inc. |
Aryl and biaryl piperidines used as mch antagonists
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
ES2464532T3
(es)
|
2001-04-19 |
2014-06-03 |
The Scripps Research Institute |
Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
|
CZ20032946A3
(en)
|
2001-04-30 |
2004-05-12 |
Glaxoágroupálimited |
Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
|
ES2299567T3
(es)
|
2001-05-05 |
2008-06-01 |
Smithkline Beecham Plc |
N-aroilaminas ciclicas.
|
EP1435955A2
(en)
|
2001-05-05 |
2004-07-14 |
SmithKline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
MY134211A
(en)
|
2001-05-18 |
2007-11-30 |
Smithkline Beecham Corp |
Novel use
|
CA2446324A1
(en)
|
2001-05-21 |
2002-11-28 |
F. Hoffmann-La Roche Ag |
Quinoline derivatives as ligands for the neuropeptide y receptor
|
AU2002257939B2
(en)
|
2001-05-21 |
2006-08-24 |
Neurocrine Inc |
Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
|
US6953801B2
(en)
|
2001-05-22 |
2005-10-11 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
|
US20050032684A1
(en)
|
2001-06-05 |
2005-02-10 |
Yalcin Cetin |
Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhaltion devices and method of diagnosis
|
CA2450579A1
(en)
|
2001-06-20 |
2003-01-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
WO2003000685A1
(en)
|
2001-06-20 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
5-membered heterocycle derivatives
|
ATE318139T1
(de)
|
2001-06-20 |
2006-03-15 |
Merck & Co Inc |
Dipeptidylpeptidase-hemmer zur behandlung von diabetes
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
DE60223920T2
(de)
|
2001-06-27 |
2008-11-13 |
Smithkline Beecham Corp. |
Pyrrolidine als dipeptidyl-peptidase-inhibitoren
|
HUP0400321A2
(hu)
|
2001-06-27 |
2004-08-30 |
Smithkline Beecham Corp. |
Fluorpirrolidin-származékok mint dipeptidil-dipeptidáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
WO2003002593A2
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
|
US7183290B2
(en)
|
2001-06-27 |
2007-02-27 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
JP2003018009A
(ja)
|
2001-06-29 |
2003-01-17 |
Mitsubishi Electric Corp |
デジタルアナログコンバータ
|
WO2003005025A1
(en)
|
2001-07-03 |
2003-01-16 |
Biovitrum Ab |
Methods for identifying compounds modulating the activity of ppar-gamma
|
WO2003004496A1
(en)
|
2001-07-03 |
2003-01-16 |
Novo Nordisk A/S |
Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
|
WO2003004027A1
(en)
|
2001-07-05 |
2003-01-16 |
Synaptic Pharmaceutical Corporation |
Substituted anilinic piperidines as mch selective antagonists
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
ITMI20011483A1
(it)
|
2001-07-11 |
2003-01-11 |
Res & Innovation Soc Coop A R |
Uso di composti come antagonisti funzionali ai recettori centrali deicannabinoidi
|
CA2453027A1
(en)
|
2001-07-12 |
2003-01-23 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
CA2453609C
(en)
|
2001-07-18 |
2010-05-04 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
WO2003007887A2
(en)
|
2001-07-20 |
2003-01-30 |
Merck & Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
WO2003007913A2
(en)
|
2001-07-20 |
2003-01-30 |
Samir Mitragotri |
Method for oral drug delivery
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
PE20030385A1
(es)
|
2001-07-26 |
2003-05-08 |
Schering Corp |
Compuestos de urea como antagonistas de receptores y5 del neuropeptido y
|
WO2003011267A1
(fr)
|
2001-07-31 |
2003-02-13 |
The Nisshin Oillio, Ltd. |
Medicaments anti-obesite et ses substances
|
GB0119172D0
(en)
|
2001-08-06 |
2001-09-26 |
Melacure Therapeutics Ab |
Phenyl pyrrole derivatives
|
WO2003014113A1
(en)
|
2001-08-06 |
2003-02-20 |
Glenmark Pharmaceuticals Limited |
Novel benzopyran compounds and process for their preparation and use
|
KR20040023731A
(ko)
|
2001-08-07 |
2004-03-18 |
반유 세이야꾸 가부시끼가이샤 |
스피로 화합물
|
CA2456964A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co., Inc. |
Melanin-concentrating hormone antagonists
|
DE60215028T2
(de)
|
2001-08-14 |
2007-03-15 |
Eli Lilly And Co., Indianapolis |
Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
|
ATE325119T1
(de)
|
2001-08-14 |
2006-06-15 |
Lilly Co Eli |
3-substituierte oxindol-beta-3-agonisten
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
EP1452521A4
(en)
|
2001-08-17 |
2007-03-14 |
Eisai R&D Man Co Ltd |
CYCLIC COMPOUND AND AGONIST OF PPAR RECEPTOR
|
US20030092041A1
(en)
|
2001-08-23 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disorders
|
JPWO2003018010A1
(ja)
|
2001-08-23 |
2004-12-09 |
三菱ウェルファーマ株式会社 |
動脈硬化作用に基づく疾患の予防及び/または治療薬
|
WO2004019872A2
(en)
|
2002-08-30 |
2004-03-11 |
Biorexis Pharmaceutical Corporation |
Oral delivery of modified transferrin fusion proteins
|
EP1421077A4
(en)
|
2001-08-31 |
2004-11-17 |
Univ Connecticut |
NEW PYRAZOLANALOGS ON CANNABINOID RECEPTORS
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
US6915444B2
(en)
|
2001-09-12 |
2005-07-05 |
Rockwell Automation Technologies, Inc. |
Network independent safety protocol for industrial controller using data manipulation techniques
|
CA2460578A1
(en)
|
2001-09-13 |
2003-03-27 |
Nisshin Pharma Inc. |
Propanolamine derivative having 1,4-benzodioxane ring
|
DE60237528D1
(de)
|
2001-09-14 |
2010-10-14 |
High Point Pharmaceuticals Llc |
Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
|
CA2459454A1
(en)
|
2001-09-14 |
2003-03-27 |
Bayer Pharmaceuticals Corporation |
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
ES2349118T3
(es)
|
2001-09-14 |
2010-12-28 |
High Point Pharmaceuticals, Llc |
Nuevos derivados de aminoazetidina, pirrolidina y piperidina.
|
WO2003024965A2
(en)
|
2001-09-19 |
2003-03-27 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
WO2003026648A1
(en)
|
2001-09-21 |
2003-04-03 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
|
WO2003026647A1
(en)
|
2001-09-21 |
2003-04-03 |
Solvay Pharmaceuticals B.V. |
Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
TWI231757B
(en)
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
JP2005532982A
(ja)
|
2001-09-24 |
2005-11-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのピロール誘導体の製造及び使用
|
WO2003026576A2
(en)
|
2001-09-24 |
2003-04-03 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Induction of brown adipocytes by transcription factor nfe2l2
|
CA2461454A1
(en)
|
2001-09-24 |
2003-04-03 |
Oregon Health And Science University |
Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
|
ES2320979T3
(es)
|
2001-09-24 |
2009-06-01 |
Imperial Innovations Limited |
Pyy-36 para la reduccion o prevencion de la obesidad.
|
EP1432708B1
(en)
|
2001-09-24 |
2005-11-30 |
Bayer Pharmaceuticals Corporation |
Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
|
UY27450A1
(es)
|
2001-09-24 |
2003-04-30 |
Bayer Corp |
Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
|
EP1432711A1
(en)
|
2001-09-26 |
2004-06-30 |
Bayer Corporation |
1,6-naphthyridine derivatives as antidiabetics
|
US20040191926A1
(en)
|
2001-09-26 |
2004-09-30 |
Zhong-Yin Zhang |
Ptp1b inhibitors and ligands
|
US6787558B2
(en)
|
2001-09-28 |
2004-09-07 |
Hoffmann-La Roche Inc. |
Quinoline derivatives
|
JP2005523237A
(ja)
|
2001-10-01 |
2005-08-04 |
大正製薬株式会社 |
Mch受容体アンタゴニスト
|
AU2002341921B2
(en)
|
2001-10-04 |
2007-05-31 |
Merck Sharp & Dohme Corp. |
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
WO2003031439A1
(en)
|
2001-10-05 |
2003-04-17 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
|
WO2003031410A1
(en)
|
2001-10-09 |
2003-04-17 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
FR2830451B1
(fr)
|
2001-10-09 |
2004-04-30 |
Inst Nat Sante Rech Med |
Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
|
JP2005508349A
(ja)
|
2001-10-09 |
2005-03-31 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
5−ht6受容体リガンドとしてのアリールスルホニル置換されたテトラヒドロ−およびヘキサヒドロ−カルバゾール
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
ES2256560T3
(es)
|
2001-10-12 |
2006-07-16 |
Bayer Pharmaceuticals Corporation |
Heterociclos de 5 mienbros que contienen nitrogeno sustituidos con felino para el tratamiento de la obesidad.
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
EP1446110A2
(en)
|
2001-10-16 |
2004-08-18 |
Structural Bioinformatics Inc. |
Organosulfur inhibitors of tyrosine phosphatases
|
CN1596249A
(zh)
|
2001-10-16 |
2005-03-16 |
雷迪实验室有限公司 |
苯并噁嗪与苯并噻嗪衍生物和含有它们的药物组合物
|
EP1438044A1
(en)
|
2001-10-19 |
2004-07-21 |
Transtech Pharma, Inc. |
Bis-heteroaryl alkanes as therapeutic agents
|
WO2003035061A1
(en)
|
2001-10-23 |
2003-05-01 |
Biovitrum Ab |
Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
WO2003035602A1
(fr)
|
2001-10-25 |
2003-05-01 |
Sankyo Company, Limited |
Modulateurs lipidiques
|
US7183415B2
(en)
|
2001-10-25 |
2007-02-27 |
Takeda Pharmaceutical Company Limited |
Quinoline compound
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
US7342117B2
(en)
|
2001-10-30 |
2008-03-11 |
Astellas Pharma Inc. |
α-form or β-form crystal of acetanilide derivative
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
JP2005511594A
(ja)
|
2001-11-09 |
2005-04-28 |
ビオヴィトルム・アクチボラゲット |
肥満の治療における、もしくは摂食量の減少のためのスルホンアミド誘導体の使用
|
CA2468067A1
(en)
|
2001-11-30 |
2003-06-12 |
Merck & Co., Inc. |
Metabotropic glutamate receptor-5 modulators
|
CN1582279A
(zh)
|
2001-11-30 |
2005-02-16 |
伊莱利利公司 |
过氧化物酶体激活的受体激动剂
|
DE60213851T2
(de)
|
2001-12-04 |
2007-09-13 |
F. Hoffmann-La Roche Ag |
Ringannelierte pyrazolderivate
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
DE10160409A1
(de)
|
2001-12-10 |
2003-06-18 |
Guenther Beisel |
Verwendung von ionischen und nichtionischen Celluloseethern zur Herstellung eines gelartigen Mittels zur Verhinderung der Resorption von Fetten aus dem Magen-Darm-Trakt
|
US6923992B2
(en)
|
2001-12-17 |
2005-08-02 |
The Chinese University Of Hong Kong |
Active compounds of Bao-Ji-Wan for anti-diarrhea and relieving gastrointestinal symptoms
|
DE60222698T2
(de)
|
2001-12-18 |
2008-06-19 |
Merck & Co., Inc. |
Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5
|
ES2295441T3
(es)
|
2001-12-18 |
2008-04-16 |
MERCK & CO., INC. |
Moduladores de pirazol heteroaril sustituido de receptor 5 metabotropico de glutamato.
|
US20030198619A1
(en)
|
2001-12-19 |
2003-10-23 |
Dong Liang C. |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
CA2470612A1
(en)
|
2001-12-19 |
2003-07-03 |
Merck & Co., Inc. |
Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
|
FR2833949B1
(fr)
|
2001-12-21 |
2005-08-05 |
Galderma Res & Dev |
NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
|
CA2470519C
(en)
|
2001-12-21 |
2009-11-17 |
Merck & Co., Inc. |
Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
|
EP1321142A1
(en)
|
2001-12-21 |
2003-06-25 |
Novartis AG |
Solid pharmaceutical composition for oral administration of Tegaserod
|
US6642381B2
(en)
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
US20030129160A1
(en)
|
2002-01-09 |
2003-07-10 |
John-Olov Jansson |
Use of Interleukin-6
|
AU2003201998C1
(en)
|
2002-01-10 |
2012-10-25 |
Imperial Innovations Limited |
Modification of feeding behavior
|
DE60301491T2
(de)
|
2002-02-27 |
2006-05-18 |
Pfizer Products Inc., Groton |
Acc-hemmer
|
EP1480618B1
(en)
|
2002-03-04 |
2009-06-03 |
Ipsen Pharma |
Sustained release drug formulations containing a carrier peptide
|
AU2003225837B2
(en)
|
2002-03-15 |
2008-11-06 |
Forest Laboratories Holdings Limited |
NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
|
US20030219479A1
(en)
|
2002-04-08 |
2003-11-27 |
Lavipharm Laboratories Inc. |
Multi-layer mucoadhesive drug delivery device with bursting release layer
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
SE0201175L
(sv)
|
2002-04-18 |
2003-10-19 |
Jonsered Cranes Ab |
Kranarrangemangstillhörig hållarenhet
|
BR0309969A
(pt)
|
2002-05-17 |
2005-04-26 |
Merck Patent Gmbh |
Uso de compostos que são eficazes como moduladores de receptores seletivos de opiáceos
|
GB0214013D0
(en)
|
2002-06-18 |
2002-07-31 |
Euro Celtique Sa |
Pharmaceutical product
|
US6991726B2
(en)
|
2002-07-01 |
2006-01-31 |
Usfilter Corporation |
Filter having a media retaining plate
|
US7041077B2
(en)
|
2002-07-19 |
2006-05-09 |
Yale University |
Uveoscleral drainage device
|
AU2003257995B2
(en)
|
2002-07-31 |
2008-05-22 |
Kuraray America, Inc. |
Ink-jet printed rigid interlayer and a process for preparing same
|
WO2004026296A1
(ja)
|
2002-09-18 |
2004-04-01 |
Ajinomoto Co., Inc. |
抗ストレス性疾患組成物
|
BR0314584A
(pt)
|
2002-09-20 |
2005-08-09 |
Pfizer |
Compostos piperidinil-imidazopiridina n-substituìda como moduladores e receptores 5-ht4
|
WO2004041195A2
(en)
|
2002-10-31 |
2004-05-21 |
Supergen, Inc. |
Pharmaceutical formulations targeting specific regions of the gastrointestinal tract
|
EP1569911B1
(en)
|
2002-12-02 |
2008-07-02 |
F. Hoffmann-La Roche Ag |
Indazole derivatives as crf antagonists
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
US20040121994A1
(en)
|
2002-12-20 |
2004-06-24 |
Anderson Steven N. |
Novel amides that activate soluble guanylate cyclase
|
JO2696B1
(en)
|
2002-12-23 |
2013-03-03 |
شركة جانسين فارماسوتيكا ان. في |
Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
|
AR042667A1
(es)
|
2002-12-26 |
2005-06-29 |
Taisho Pharmaceutical Co Ltd |
Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico
|
WO2004064769A2
(en)
|
2003-01-21 |
2004-08-05 |
Hector Herrera |
Methods for making and using topical delivery agents
|
US20060281682A1
(en)
|
2003-01-28 |
2006-12-14 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
SG168407A1
(en)
|
2003-01-28 |
2011-02-28 |
Ironwood Pharmaceuticals Inc |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
ZA200409537B
(en)
|
2003-01-31 |
2006-10-25 |
Yamanouchi Pharma Co Ltd |
Stable solid medicinal composition for oral administration
|
US6683072B1
(en)
|
2003-02-04 |
2004-01-27 |
Vela Pharmaceuticals, Inc. |
Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
|
US20070037741A1
(en)
|
2003-03-11 |
2007-02-15 |
Daryl Baldwin |
Novel compositions and methods for the treatment of immune related disease
|
US20050004155A1
(en)
|
2003-04-08 |
2005-01-06 |
Boyd Thomas A. |
Use of methylnaltrexone to treat irritable bowel syndrome
|
AU2004235907B2
(en)
|
2003-05-05 |
2007-08-30 |
F. Hoffmann La-Roche Ag |
Fused pyrimidine derivatives with CRF activity
|
EP1624875A4
(en)
|
2003-05-16 |
2010-01-20 |
Vela Acquisition Corp |
TREATMENT OF GASTROINTESTINAL DYSFUNCTION AND RELATED LOADS WITH ENANTIOMERIC PURE (R) 2,3-BENZODIAZEPINE
|
US7173010B2
(en)
|
2003-05-19 |
2007-02-06 |
Regents Of The University Of Michigan |
Orphanin FQ receptor
|
US7073363B2
(en)
|
2003-05-20 |
2006-07-11 |
Schumag Ag |
Method for processing drawn material and drawn material production installation
|
US7494979B2
(en)
*
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
PT1644021E
(pt)
|
2003-06-13 |
2013-01-30 |
Ironwood Pharmaceuticals Inc |
Métodos e composições para o tratamento de distúrbios gastrointestinais
|
DE10331723A1
(de)
|
2003-07-11 |
2005-06-16 |
Merck Patent Gmbh |
Kappa-Agonisten
|
KR100782918B1
(ko)
|
2003-09-19 |
2007-12-07 |
펜웨스트 파머슈티칼즈 컴파니 |
지연 방출성 제형
|
US20070259033A1
(en)
|
2003-09-26 |
2007-11-08 |
Evangeline Cruz |
Controlled release formulations exhibiting an ascending rate of release
|
MXPA06003619A
(es)
|
2003-09-30 |
2008-01-14 |
New River Pharmaceuticals Inc |
Composiciones farmaceuticas para prevencion de sobredosis o abuso.
|
US7002015B2
(en)
|
2003-10-14 |
2006-02-21 |
Bristol-Myers Squibb Company |
3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants
|
US7291125B2
(en)
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
ES2373937T3
(es)
|
2003-11-21 |
2012-02-10 |
Commonwealth Scientific And Industrial Research Organisation |
Sistemas gastro-intestinales de administración.
|
US20050136121A1
(en)
|
2003-12-22 |
2005-06-23 |
Shear/Kershman Laboratories, Inc. |
Oral peptide delivery system with improved bioavailability
|
AU2004308973A1
(en)
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
US20050267197A1
(en)
|
2004-05-25 |
2005-12-01 |
Roger Berlin |
Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses
|
WO2006012264A1
(en)
|
2004-06-25 |
2006-02-02 |
Thomas Jefferson University |
Compounds of the inventions of guanylyl cyclase c
|
US20060013889A1
(en)
|
2004-07-16 |
2006-01-19 |
Playford Raymond J |
Colostrum-based treatment for irritable bowel syndrome
|
KR20070039593A
(ko)
|
2004-07-21 |
2007-04-12 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 이용한 생합성 폴리펩티드
|
TWI536429B
(zh)
|
2004-11-18 |
2016-06-01 |
尼康股份有限公司 |
A position measuring method, a position control method, a measuring method, a loading method, an exposure method and an exposure apparatus, and a device manufacturing method
|
CA2619650A1
(en)
|
2005-08-19 |
2007-02-22 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20070101158A1
(en)
|
2005-10-28 |
2007-05-03 |
Elliott Robert C |
Security region in a non-volatile memory
|
US20090192083A1
(en)
|
2006-02-24 |
2009-07-30 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7692307B2
(en)
|
2006-12-08 |
2010-04-06 |
Intel Corporation |
Compliant structure for an electronic device, method of manufacturing same, and system containing same
|
US8779090B2
(en)
|
2007-02-26 |
2014-07-15 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of heart failure and other disorders
|
EP2152266A4
(en)
|
2007-05-04 |
2010-07-28 |
Ironwood Pharmaceuticals Inc |
COMPOSITIONS AND METHODS OF TREATING DISORDERS RELATED TO SALT OR LIQUID RETENTION
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
DK2170930T3
(da)
|
2007-06-04 |
2012-11-05 |
Synergy Pharmaceuticals Inc |
Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
|
EP2296685B1
(en)
|
2008-06-04 |
2015-09-02 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
AU2009322285B2
(en)
|
2008-12-03 |
2016-07-28 |
Bausch Health Ireland Limited |
Formulations of guanylate cyclase C agonists and methods of use
|
US20140179607A9
(en)
*
|
2009-11-09 |
2014-06-26 |
Ironwood Pharmaceuticals, Inc |
Treatments for Gastrointestinal Disorders
|
KR20120103689A
(ko)
*
|
2009-12-07 |
2012-09-19 |
아이언우드 파마슈티컬스, 인코포레이티드 |
위장 장애의 치료
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
WO2012037380A2
(en)
|
2010-09-15 |
2012-03-22 |
Synergy Pharmaceuticals Inc. |
Formulations of guanylate cyclase c agonists and methods of use
|
ES2664873T3
(es)
|
2011-03-01 |
2018-04-23 |
Synergy Pharmaceuticals Inc. |
Proceso de preparación de agonistas de guanilato ciclasa C
|
EP2958577A2
(en)
|
2013-02-25 |
2015-12-30 |
Synergy Pharmaceuticals Inc. |
Guanylate cyclase receptor agonists for use in colonic cleansing
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
EP3065757A4
(en)
|
2013-10-09 |
2017-08-23 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|